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ABSTRACT
ECOLOGICAL, EVOLUTIONARY, AND MOLECULAR MECHANISMS DRIVING
PYOCIN DIVERSITY IN PSEUDOMONAS AERUGINOSA
Aubrey A. Mojesky
April 12, 2021
Bacteriocins are narrow-spectrum antibiotics produced in nearly all
lineages of bacteria, meaning that these antimicrobials target closely related
individuals. The bacteriocins of Pseudomonas aeruginosa, called pyocins, are
highly prevalent and diverse in populations of this species. Laboratory studies
have shown that pyocins can function to mediate the outcome of interactions,
often allowing for the coexistence of multiple strains, as no one pyocin genotype
is competitively superior. Although this has been demonstrated under laboratory
conditions, the function of pyocins in natural settings and the ecological,
evolutionary, and genetic mechanisms underlying pyocin diversity remains
unclear. As such, for my dissertation, I conducted research that investigated the
driving forces underlying diversity in pyocin phenotype and genotype in free-living
isolates of P. aeruginosa.
In Chapter II, I collected P. aeruginosa isolates from spatially structured
household bathroom and kitchen sink drains to examine relationships among
pyocin phenotype with spatial structure, environment of isolation, resource
competition, and phylogenetic distance. I found isolates from different houses
iv

and different drain types to vary in pyocin-mediated inhibition, suggesting that
dispersal limitations and environmental conditions help shape pyocin diversity. I
also found that pyocin-mediated inhibition was most likely to occur between
isolates that were intermediately phylogenetically related, but inhibition was not
driven by resource competition.
In Chapter III, I searched genome sequences of the isolates in my
collection for pyocin genes to investigate the relationships between pyocin
genotype and spatial structure, environment of isolation, and pyocin phenotype. I
found isolates collected from bathroom sink drains to encode more pyocin genes
than those collected from kitchen sink isolates, and isolates from different houses
varied primarily with respect to pyocin immunity genes. These findings indicate
that environment of isolation and, to a lesser extent, spatial structure contribute
to differences in pyocin gene content. I found that while immunity genes and
particular killing genes partially contribute to the outcome of inhibitory
interactions, pyocin-mediated inhibition is a complex process likely driven by
differing levels of expression, alternative mechanisms of resistance, and receptor
specificity.
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CHAPTER I
GENERAL INTRODUCTION
Bacterial Biogeography
Biogeography is a discipline that seeks to characterize the patterns of
biodiversity over space and time as well as gain an understanding of the
processes underlying these observed patterns. Biogeography has long been
studied in macro-organisms, such as plants and animals, and it has been welldocumented that these systems exhibit particular biogeographic patterns [1, 2].
Conversely, the patterns that might arise in bacterial biogeography have
historically been unexplored. However, advancements in sequencing
technologies now allow for deeper investigations into bacterial diversity, and this
has increased the capability to investigate biogeographic patterns in these
organisms [3, 4].
Martiny et al. [5] defined four hypotheses that seek to understand the
processes influencing bacterial biogeographic patterns. The first, a null
hypothesis, is that these organisms do not exhibit biogeographic patterns,
meaning they are randomly distributed in space. The second hypothesis is often
referred to as the Baas-Becking Hypothesis: “Everything is everywhere – the
environment selects” [6], suggesting that the distribution of bacteria reflects only
current abiotic and biotic conditions in the environment. A third hypothesis
proposes that bacterial patterns are influenced by historical
1

conditions such as dispersal limitations and past environmental conditions. The
last hypothesis combines the second and third hypotheses by arguing that
patterns of diversity in bacteria reflect both current conditions and past events
[5].
Empirical studies have widely demonstrated that free-living bacterial
species display non-random biogeographic patterns in nature [7-10], which
allows us to reject the null hypothesis. Overall, it appears that both current
environmental conditions and historical processes affect bacterial composition,
suggesting that the last hypothesis proposed by Martiney et al. [5] may most
accurately reflect the biological underpinnings of bacterial biogeography. Studies
in bacterial populations have examined relationships between diversity and
geographic distance, which provides insight into the historical processes
underlying observed patterns of diversity, such as dispersal limitations as well as
previous selection and drift. Large-scale intercontinental studies in
Synechococcus [11] and Sulfolobus [7] assemblages have revealed strong
effects of geographic distance on bacterial and archaeal composition,
respectively. Furthermore, studies done at smaller spatial scales in
Pseudomonas fluorescens [12] and among species in the Xenorhabdus genus
[13] have revealed genotypic and phenotypic differences among geographically
isolated bacteria. Some studies, however, have not identified this pattern [14],
suggesting that the detection of such a relationship varies among studies, taxa,
methodology, and perhaps, to an extent, the scale of the study.
Additionally, studies in bacterioplankton, microbial communities in aquatic
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environments, and soil bacterial communities in rhizospheres have found that
contemporary environmental conditions play a significant role in influencing
bacterial composition [15, 16], which supports the Baas-Becking Hypothesis.
While less common, some studies examine the effects of both geographic
distance and environmental conditions on bacterial composition and have found
evidence signifying that both factors play an important role in shaping patterns of
distribution in these organisms [8, 10, 17]. Taken together, these findings indicate
that historical events and current conditions can contribute to patterns of bacterial
diversity, but the degree of this influence may be dependent upon the scale of
the study as well as the study system.
Notably, at least some dispersal limitation is required to detect a
relationship between geographic distance and diversity because differentiation
due to past events would be countered by homogenizing selection imposed
under high rates of dispersal [18]. The detection of such a relationship with
geographic distance can also be impacted by a bacterial taxon’s ability to
colonize a new location [5]. For example, some taxa are more tolerant to
stressful conditions and, therefore, may be able to more easily colonize new
locations than other taxa that are more fastidious. A study done using species in
the Bacillus genus showed that this spore-forming organism has high rates of
migration, which minimizes the influence of geographic distance on these
populations [19]. Additional factors that may play an important role in the
colonization rate of a bacterium are interactions with residents of a new location,
including competitive and synergistic interactions, and population density, as a
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higher population density would allow for colonization more easily. The type of
environment will also play a role in a bacterium’s dispersal capabilities; certain
habitats, such as those in aquatic settings, will allow for higher rates of dispersal
than those in terrestrial environments [5].
Due to the small number of studies addressing the effects of both
geographic distance and current environmental conditions, more research is
needed across different taxa to identify the specific mechanisms underlying
bacterial biogeography. In this dissertation, by using strains of Pseudomonas
aeruginosa collected from spatially structured kitchen and bathroom sink drains
across different houses, I explored the extent to which these previously
mentioned underlying mechanisms contributed to patterns of diversity observed
in my strain collection.

Bacterial Competition
The effects of biotic factors, such as the composition and abundance of
other microorganisms, are often neglected in studies of bacterial biogeography.
However, when examined, bacterial composition often correlates to measured
biotic variables, suggesting that processes due to biotic variables may play a role
in shaping patterns of bacterial biogeography [20].
One biotic variable contributing to patterns of bacterial diversity is
competition over shared resources. Like macro-organisms, bacteria compete
over shared, limiting resources such as carbon, nitrogen, and metals [21].
Resource competition can be placed into two categories: scramble (passive) and
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interference (contest) competition [22]. Scramble competition among
microorganisms occurs when organisms compete indirectly through rapid growth
or through the secretion of extracellular molecules used to obtain nutrients [20].
For example, the bacterial species Escherichia coli can shift its metabolism in the
presence of oxygen, which allows it to grow more quickly and take up nutrients
faster than its competitors [23].
Another form of scramble competition is mediated through the production
and release of extracellular molecules such as siderophores, which are ironscavenging compounds that can obtain free iron in the environment for use by
the producing cell. While siderophores could help to mediate competitive
interactions due to differences in iron-binding affinities of different siderophore
molecules [24], production of these iron-binding molecules may also be
considered a cooperative behavior because, when they are produced, the bound
iron is considered a “public good” and can be taken up by other bacterial cells in
some cases [25]. Consequently, this can sometimes lead to “cheating,” a
phenomenon in which cells can exploit a resource produced by a competitor
without expending the energy to manufacture the product themselves. In other
words, cells may lose the ability to produce and release siderophores but retain
the ability to take up the iron bound to them [26-29]. Another example of
cooperation and consequential cheating in P. aeruginosa occurs during a
process called quorum sensing (QS) that allows bacterial cells to communicate
through the release of signal molecules. The observance of “cheaters” in this
process has been identified when cells benefit from this process but do not
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produce the QS molecules themselves [30, 31].
Interference competition occurs when organisms compete by directly
damaging one another. One such type of interference competition in bacteria is
contact-dependent and mediated through the Type VI secretion system (T6SS),
in which a needle-like apparatus is used to inject toxins directly into a target cell
[32]. Another mechanism of interference competition is the secretion of
antimicrobial compounds, which is widespread in all lineages of bacteria [5, 20]
Some researchers have proposed that, instead of modulating competitive
interactions, sub-inhibitory levels of antimicrobials could function as signaling
molecules for cell-to-cell communication purposes [33]; however, numerous
empirical studies in laboratory settings have shown that the production of these
molecules does, in fact, play a significant role in mediating the outcomes of
competitive interactions [34].
Furthermore, the killing range of a cell that is secreting antibiotics (the
“producing cell”) can often be correlated to its habitat and lifestyle, further
providing evidence of these compounds' role in natural settings. As such, a
generalist species that inhabits a diverse microbial habitat may benefit from the
production of broad-spectrum antimicrobials that are effective against a wide
range of microorganisms due to the variety of competitors it is likely to encounter.
For example, species in the Streptomyces genus are commonly found in highly
diverse environments such as in soils, and organisms in this bacterial genus
carry genes for a wide array of antimicrobial compounds [35]. On the other hand,
a specialist species with specific habitat requirements may be more likely to
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produce narrow-spectrum antibiotics that are effective against a smaller, more
targeted group of microorganisms as it is not likely to encounter a diverse group
of competitors [36]. Therefore, the production of antimicrobials plays an important
role in mediating competition both within and between species.
The long-term evolutionary consequence of bacterial competition is a
reduction in diversity at a local scale – the scale at which cells directly interact
and impact one another. This is due to competitive exclusion, a phenomenon in
which one organism outcompetes the other and drives it to extinction [37]. These
interactions may also drive organisms to specialize on different resources and
occupy new niches (niche partitioning) or, in the presence of spatial structure,
microorganisms may have the capacity to coexist [36]. This dissertation explores
the patterns of diversity in narrow-spectrum antibiotics, called bacteriocins,
observed at different spatial scales and investigates the potential evolutionary
remnants of competition mediated through these compounds' production.

Hamilton’s Theory of Inclusive Fitness
Social behaviors such as altruism and spite are another mechanism
underlying bacterial diversity. Darwin’s theory of natural selection predicts that
traits associated with greater reproductive success will be acted upon by
selection and accumulate in natural populations [38]. Consequently, selection for
social behaviors such as selfishness and mutualism are well supported by
Darwin’s ideas as these interactions will lead to an increase in reproductive
success for the actor, who is the individual initiating the behavior, or both the
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actor and the recipient, who is the individual targeted by the behavior [39]. Less
clear, however, are the reasons behind other social behaviors, such as altruism
and spite, that may decrease the reproductive output of the individual initiating
the behavior [40, 41]. The reasoning underlying these behaviors is difficult to
understand as the actor will incur a fitness cost when performing altruistic or
spiteful actions to provide a benefit, in the case of altruism, or to harm, in the
case of spite, the individual on the receiving end of the behavior.
In the 1960s, Hamilton noted that behaviors such as altruism and spite
could not be explained by Darwin’s theories alone; however, they could be
supported by the principle of inclusive fitness [40, 41]. Hamilton developed a
theory that defined inclusive fitness as the sum of direct fitness, which is gained
through producing offspring, and indirect fitness, which is obtained through
interactions with close kin or individuals of common descent. He argued that
although altruism and spite decrease an individual’s direct fitness, these
behaviors may increase indirect fitness, thereby maximizing inclusive fitness [40,
41].
Altruism, the more studied and well understood of these social behaviors,
is predicted to occur if the indirect fitness benefits are aimed toward individuals
with high genetic relatedness to the actor; this action will increase the frequency
of the genes shared by the individuals participating in this interaction [40, 41].
This behavior, mathematically modeled by Hamilton, will be favored by selection
when rb-c>0, where r is genetic relatedness between the actor and recipient, b is
the fitness benefit to the recipient, and c is fitness cost to the actor [40, 41].

8

Altruism is clearly observed in highly eusocial insects, such as ants and bees, in
which sterile workers give up the opportunity for independent reproduction to
help individuals with high genetic relatedness, or their kin [42]. As a result, these
interactions are often referred to as “kin selection” [43]. Another well-studied
example of altruism exists in a group of social amoebae, often referred to as
slime molds, particularly within the species Dictyostelium discoideum [44]. Under
normal conditions, D. discoideum exists in a unicellular form; however, under
conditions of low nutrients, these cells come together to form a multicellular slug.
This slug transforms into a fruiting body through the differentiation of cells into a
cluster of spores or into a long, rigid stalk, which supports the cluster of spores.
The cells that make up the stalk are nonviable, and about 20% of these cells will
die to support the reproduction of cells that have differentiated into spores in
what appears to be a classic example of altruistic behavior [44].

Spite – the Dark Side of Altruism
Spite, the darker side of altruism, refers to behaviors that decrease the
reproductive output of both the actor and the recipient [45]. Because spite is less
understood and more rarely observed than altruism, it has been historically
confused with selfishness, which harms a recipient but leads to a direct fitness
increase for the actor. Selfish behaviors differ from spite, as truly spiteful
behaviors must be costly in terms of fitness to both the actor and the recipient
[39]. Spiteful behaviors can be explained by Hamilton’s theory of inclusive fitness
because, like altruism, spite maximizes inclusive fitness through a decrease in
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direct fitness with a subsequent increase in indirect fitness [40, 41]. Like altruism,
spite will be favored when rb-c>0; with spiteful behaviors, however, r is a
negative genetic relatedness, meaning that the recipient is less related to the
actor than the average member of the population. Furthermore, b is a negative
benefit, meaning that the action has a negative impact on the recipient, and c is
positive, meaning that the action is also costly to the actor. Therefore, a spiteful
behavior will be favored if the negative genetic relatedness and negative impact
on the recipient can outweigh the cost to the actor [40, 41, 45]. Contrasting with
this theory is Wilsonian spite, which predicts that, in order for a spiteful behavior
to occur, the indirect beneficiary of the spiteful behavior must be more genetically
related to the actor than the individual on the direct receiving end of the behavior
[46, 47]. Spite is rarely observed in nature as the particular population conditions
that favor harming non-relatives to effectively help relatives are quite difficult to
obtain [39, 45]; however, one clear example of a spiteful behavior is the bacterial
production of anticompetitor toxins, such as bacteriocins [45].

Bacteriocins – Spiteful, Narrow-spectrum Antibiotics
Bacteriocins, a diverse family of antimicrobial toxins found in upwards of
99% of Gram-negative and Gram-positive bacteria, are often cited as a classic
example of spite, as these antibiotics result in a fitness cost to both the actor and
the recipient [45, 48, 49]. As well as being costly to produce, bacteriocins are
also typically released through lysis in Gram-negative bacteria, which kills the cell
producing and releasing the bacteriocin [48]. Moreover, laboratory studies have
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demonstrated that, when grown alone, bacteriocin producers have a slower
growth rate than non-producers, which shows the cost of carrying these toxins on
reproductive fitness [48]. Unlike traditional antibiotics, bacteriocins are
conventionally believed to have a relatively narrow killing spectrum, meaning that
the capacity for killing by a bacteriocin producer is restricted to members of the
same species or closely related species. This specificity results from the
bacteriocin’s requirement to bind to a particular receptor on the surface of a
target cell in order for killing to occur [48]. However, recent research has shown
that this general assumption does not hold for all bacteriocin-producing
organisms [50-52]. For example, a study in enteric bacteria, such as E. coli and
members of the Klebsiella genus, found that many of the strains used in this
study exhibited a surprisingly high level of interspecific inhibition with many
strains able to inhibit members of different taxa [52]. Additionally, the bacteriocins
of Pseudomonas aeruginosa, called pyocins, have the potential to be effective
against other species in the Pseudomonas genus and species in the
Burkholderia genus [50,51]. However, these studies confirm that, to an extent,
traditional assumptions of the narrow killing spectrum hold true as bacteriocinmediated inhibition has been found to occur more frequently within a species
compared to interactions observed between different species.
Laboratory studies have demonstrated that, under certain conditions, the
bacteriocins of E. coli, called colicins, have the ability to play important roles in
maintaining intraspecies diversity through the creation of non-transitive networks,
sometimes referred to as rock-paper-scissors networks, in which multiple strains
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can coexist due to different colicin genotypes and mechanisms of resistance [53].
For example, it is possible to have a strain capable of producing a bacteriocin,
which may give it a competitive advantage over a strain that is sensitive to the
bacteriocin. However, because these toxins are costly to carry and release, the
producer is at a disadvantage because it has to pay this cost while the sensitive
strain does not. Additionally, there could also exist a non-producing, resistant
strain that cannot be killed by the producer but must pay the cost of resistance,
usually through a mutation in the cell surface receptor, which is not paid by the
sensitive strain. Therefore, a non-transitive rock-paper-scissors network can be
maintained in which no one strain can outcompete the other [53]. However, the
maintenance of such a network is dependent upon rates of dispersal and will be
preserved only under conditions in which dispersal is limited, and therefore
interactions occur locally, such as that of a static agar plate [34, 53, 54]. When
rates of dispersal are high and interactions are occurring globally, such as within
a shaking flask, the resistant strain can competitively exclude both the producer
and sensitive strain as a result of homogenizing selection [34,53].
Bacteriocin diversity in nature has been explored in previous studies [12,
14, 51, 55-58]; however, it remains unclear if this diversity is a result of historical
or contemporary processes, or if these antibiotics are playing an active,
functional role in the maintenance of overall microbial diversity, thereby
contributing to the structure of natural microbial assemblages. Furthermore, it is
unclear if bacteriocin production is, in fact, a truly spiteful behavior and if the
proposed genetic mechanisms driving such a behavior can be detected in natural
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microbial populations. This dissertation addresses the relationship between
genetic relatedness and spiteful interactions mediated through the production of
bacteriocins in P. aeruginosa. This was done by observing bacteriocin-mediated
interactions among the P. aeruginosa isolates in my collection and measuring the
phylogenetic distance between them. Specifically, this work seeks to elucidate
the mechanisms underlying bacteriocin diversity by investigating patterns in
genotype and phenotype among environmental isolates of P. aeruginosa.

Pseudomonas aeruginosa – a Versatile, Opportunistic Pathogen
Pseudomonas aeruginosa is a Gram-negative opportunistic pathogen
perhaps most widely known and studied for causing chronic infections in
individuals with Cystic Fibrosis (CF), an autosomal recessive disorder caused by
a mutation in the cystic fibrosis transmembrane conductance regulator (CFTR)
[59, 60]. This mutation leads to a buildup of thick mucus in the lungs, which
allows for sustained bacterial colonization. P. aeruginosa is one of the leading
causes of morbidity and mortality in these individuals [60]; once this organism
colonizes the lungs of an individual with CF, it is nearly impossible to eradicate
[60]. This species is also responsible for a wide variety of infections including
those in wounds, burns, and other nosocomial infections [61].
Pseudomonas aeruginosa PAO1, the most commonly studied and wellcharacterized laboratory strain of P. aeruginosa, has a relatively large genome
size comprised of ~6.3 million base pairs with a GC content of ~66.6% and 5,570
predicted open reading frames (ORFs) [62]. For comparison, E. coli has a
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genome size of 4.6 million base pairs with a GC content of 50.8% and 4,288
predicted open reading frames [63]. The large genome size of P. aeruginosa is
thought to be due to increased genetic complexity and functional diversity.
Compared to other well-studied bacterial species such as E. coli, Mycobacterium
tuberculosis, and Bacillus subtilis, P. aeruginosa has more distinct paralogous
groups of genes, or genes that have resulted from gene duplication but are
functionally distinct from one another [62]. Furthermore, P. aeruginosa PAO1
was found to have a large number of transcriptional regulators and environmental
sensors as well as diverse metabolic pathways and enzymes related to oxidative
metabolism. Taken together, these components indicate that the genetic intricacy
and regulatory flexibility, as well as variable metabolic capabilities, allow P.
aeruginosa to persist in a wide variety of environmental conditions [62].

P. aeruginosa in the Built Environment
P. aeruginosa has historically been characterized as an organism with a
broad fundamental niche, meaning that it has the ability to persist in a wide array
of environmental conditions [62]. As such, this species has long been perceived
as a global or ubiquitous organism. This has been an accepted hypothesis
because P. aeruginosa is known for its wide metabolic capabilities and has also
been isolated from a diverse array of environments including soils, water, and
marine environments. Furthermore, as this is a particularly significant pathogen
for individuals with CF, it has been of interest to determine the initial source of P.
aeruginosa infection in these individuals. While patient-to-patient transmission of
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P. aeruginosa has been well documented [64-66], other potential sites harboring
this species remain unclear. It is possible that certain environmental reservoirs of
P. aeruginosa may also serve as a source of infection for these individuals.
To determine potential sources of initial infection, studies have examined
P. aeruginosa distribution within the built environment, with a particular focus on
hospital settings. In these environments, P. aeruginosa has been isolated from
places such as sinks, drains, and water [67-70]. Additionally, previous studies
have focused on identifying potential sources of P. aeruginosa within
households, as this setting may also harbor P. aeruginosa [71-74]. Although P.
aeruginosa is often referred to as ubiquitous, studies that have sampled the
households of either individuals with CF or the households of individuals without
CF, have found that P. aeruginosa is not always recovered, which contrasts with
the perception that this is a global organism with a broad fundamental niche. In
fact, Remold et al. [74] found that P. aeruginosa was never recovered from
indoor or outdoor soils and was rarely recovered from tap water samples, despite
previous studies reporting isolating P. aeruginosa from these sources [75-77].
Another study, however, supports the findings of Remold et al. [74] through the
observation that P. aeruginosa occurrence is rare in agricultural soil samples
[77].
When P. aeruginosa is recovered from a household, it appears that this
organism displays a high specificity in these environments, as it is most
frequently recovered from the drains of kitchen sinks, bathroom sinks, showers,
or toilets. Furthermore, some studies report that P. aeruginosa shows specificity
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to sub-categories of sampling locations such as types of drains. For example,
Remold et al. [74] found P. aeruginosa to be isolated significantly more often
from bathroom sink drains than kitchen sink drains. However, other studies,
including another study done by Remold et al. [73] have not identified this
pattern. In fact, Regnath et al. [71] recovered P. aeruginosa from 35% of kitchen
sink drains and 34% of bathroom sink drains. The potential differences in
recovery rates from bathroom and kitchen sink drains could be due to a variety of
biotic and abiotic factors or from sampling bias. Regnath et al. [71] proposed that
sinks used more frequently may be less likely to harbor P. aeruginosa because
the increase in water flow may displace bacterial cells. These sampling studies
indicate that, while P. aeruginosa is described as having the ability to persist in a
wide array of environmental conditions, its realized niche, or the distribution that
this organism actually exhibits in nature, appears to be much more constrained
than its fundamental niche.
This dissertation continues the work in investigating the distribution of P.
aeruginosa in households; however, we instead focus on sampling only
bathroom and kitchen sink drains, as we know these are the locations most likely
to harbor P. aeruginosa and this allowed us to investigate potential differences in
recovery from different types of sink drains.

Pyocins – the Bacteriocins of P. aeruginosa
The bacteriocins of P. aeruginosa, called pyocins in this species, are one
of the more well-characterized bacteriocin systems. Pyocins differ from
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bacteriocins produced in other species in that they are both highly abundant in P.
aeruginosa populations as well as incredibly diverse. The pyocins of P.
aeruginosa display variability in genetic structure, mode of action, and killing
range. Furthermore, unlike the bacteriocins of other species, which are located
on plasmids, pyocins are chromosomally encoded [78, 79]. Pyocins have been
placed in three categories: S, R, and F. The S-type pyocins are soluble and
share homology to the colicins of E. coli, while the R- and F- type pyocins are
multiprotein molecules that are similar to bacteriophage [80]. There are multiple
subtypes within each of these categories and strains have the ability to carry
unique combinations of each type [80]. The S, R, and F pyocins are discussed in
more detail later in this chapter.

Regulation of Pyocin Expression
Due to the costly nature of pyocin production and release [80], pyocin and
other associated genes are not constitutively expressed, meaning that these
proteins are not always present in the cell. Instead, these genes are regulated
through the SOS response, which occurs when bacteria respond to DNA damage
[80-82]. While the SOS response in P. aeruginosa is more complex than that of
other species like E. coli, the mechanism of pyocin expression as it relates to this
response is similar in that it is also coordinated through the production of a
protein called RecA (Fig. 1). Under conditions in which DNA damage occurs, a
nucleoprotein called RecA will mediate the autocleavage of a protein called PrtR.
Under normal conditions, PrtR acts as a repressor for prtN, a gene that encodes
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for an activator of pyocin expression. However, under stressful conditions, PrtR is
cleaved, which derepresses prtN and allows for synthesis of its protein. PrtN
binds to particular sequences called P-boxes in the promotor regions of S, R, and
F-type pyocins [81]. This process leads to the expression of all pyocin genes as
well as a presumptive group of lysis genes that allow for the release of the
pyocins from the cell [83]. Both prtN and prtR are conserved across strains of P.
aeruginosa, which suggests that this regulatory system for pyocin expression is
conserved throughout this species [81, 82]. However, It is notable, that while Pboxes have been identified upstream of the majority of pyocins, an S-type pyocin
called S5 does not have an identifiable P-box sequence, suggesting that this
pyocin may have a different regulatory pathway than that of other pyocins [84].
A

S pyocin
recA

prtR

prtN

P-boxes

R pyocin
F pyocin

PrtR

B
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recA

prtR

prtN
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R pyocin

S

R
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Inducer

F
RecA

PrtR

PrtN
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Figure 1. Regulation of pyocin gene expression under normal conditions (A) and
under conditions in which pyocin expression is induced (B) through stress or
DNA damage.
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S-type Pyocins
The S-type pyocins contain many subtypes, S1-S6 as well as AP41, that
have been empirically confirmed to demonstrate bactericidal activity [80].
Additionally, there are presumptive subtypes S7-S12, which have been predicted
through P. aeruginosa genomic analysis [85]. The subtypes of S-type pyocins
exhibit diversity in genetic structure, mode of action, and receptor specificity.
The genetic determinants of S-type pyocins share homology to the colicins
of E. coli [80]. Colicin gene clusters have three components: a toxin gene
responsible for killing activity, an immunity gene providing protection for the
producer cell, and a lysis gene that enables a producing cell to release the toxin
(Fig. 2) [48, 86]. The immunity gene provides protection for the producer cell
because when this protein is synthesized, it will bind to and inactivate the toxin
protein [48]. While the majority of S-type pyocins share this genetic organization
[79, 87], previous studies have shown that some strains will lack a toxin gene but
carry the corresponding immunity gene, which, in these instances, is referred to
as an “orphan” gene [55, 88]. Additionally, S-type pyocins do not appear to have
an identifiable lysis gene expressed alongside the toxin and immunity genes (Fig.
2) [80]. It has been proposed, however, by Nakayama et al. [83] that S-type
pyocins may be released from a producer cell using a lysis cassette that is
encoded in the R -and F-type pyocin gene cluster, which is discussed later in this
chapter.
All identified S-type pyocin toxin and immunity genes are organized in
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operons composed of two open reading frames (ORFs), which code for both of
these genes [79, 80, 87]. In studies on the molecular structures of S1 and S2
pyocins, the two ORFs for both pyocin types were found in close proximity; in
fact, the stop codon of the ORF encoding the toxin gene is separated by the start
codon for the ORF encoding the immunity gene by a single nucleotide and the
presumptive ribosome binding site for the immunity gene is located within the
region encoding the terminal portion of the toxin gene. This operon organization
suggests that, in pyocins S1 and S2, the toxin and immunity genes are translated
together because this structure allows for continuous contact of the ribosome
with the mRNA during translation [79]. Despite this operon organization,
however, one study has shown that immunity proteins may be expressed singly,
particularly under non-stressful conditions, perhaps due to regulation through
small non-coding RNAs [89].

A
colicin

immunity

pyocin

immunity

lysis

B

Figure 2. General genetic structure of a colicin in E. coli (A) and S-type pyocin in
P. aeruginosa (B).
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S-type pyocins have a diverse array of modes of action to kill their
sensitive competitors. Pyocins S1, S2, S3 and AP41 kill their sensitive
competitors via DNase activity [79, 80, 90, 91]. In addition to DNase activity, it
has been proposed that pyocin S2 can target sensitive competitors through the
inhibition of phospholipid synthesis, although the mechanism underlying this
inhibition is not well understood [92]. Additionally, pyocin AP41 has been shown
to induce expression of R- and F-type pyocins as well as bacteriophage in a
sensitive target cell [87]. Pyocin S4 is presumed to kill via tRNase activity, S6 has
rRNase activity, and the mode of action for S5 is pore formation, which leads to
membrane damage and leakage of cellular contents [80, 93].
In order to kill a sensitive competitor, S-type pyocins must bind to specific
cell surface receptors and subsequently be translocated into a target cell [80].
Subtypes vary in their receptor specificity, which, in addition to the presence of
immunity genes, could also account for variability in killing spectra among
different S-type pyocins. Pyocins S1, S2, S3 and S4 are taken into target cells
via outer membrane ferripyoverdine receptors, which, under iron-limited
conditions, are used in the uptake of siderophores. S2 and S4 [94] share the
same receptor, siderophore ferripyoverdine receptor FvdAI, while S3 uses FvdAII
[95] and S5 uses the FetA ferripyochelin receptor [93]. Consequently, these
pyocins are better absorbed by sensitive cells under iron-limited conditions, due
to an increase in the number of ferripyoverdine receptors on the surface of a
sensitive target cell [96]. Researchers have been unable to find a specific
receptor for pyocin S6, suggesting that perhaps this pyocin type does not target a
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particular type of ferripyoverdin receptor [89]. Similarly, the receptor for AP41 has
not been definitively identified; it is believed to be a different receptor than those
of pyocins S1-S4, but one in which iron is also involved [80, 95]. Once pyocins
have bound to the appropriate receptors, they must be translocated into the
sensitive target cell. While little is known about the mechanism of translocation
for S-type pyocins, it has been proposed that because of the use of
ferripyoverdine receptors in S1-S4, these pyocins may be moved into the target
cell through a mechanism that is similar to that of the uptake of ferrisiderophore,
which is the TonB system [97]. The mechanism by which AP41 is translocated
has not yet been identified, but it is theorized that this pyocin may use the
TolQRAB system, which is an uptake pathway involved in the translocation of the
colicins of E. coli as well as certain types of bacteriophage [80, 98].

Pyocin S3
Pyocin S3 ws first identified in 1995 in a strain isolated in sputum from an
individual with CF [99] and is distinguishable from other S-type pyocins [78, 80].
When compared to pyocins S1, S2, and AP41, S3 shares little homology with
these subtypes regarding to the killing or immunity proteins [78, 80]. Additionally,
the GC contents of the killing and immunity genes in pyocin S3 were determined
to be 56.6% and 42.7%, respectively, which is lower than that of the P.
aeruginosa genome (66.6%) [90]. In addition to the RecA-mediated regulation
that all pyocins share, pyocin S3 had additional transcriptional regulation factors
at play. A small non-coding RNA, PesA, which is transcribed within the
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pathogenicity island PAPI-1, is commonly found in clinical isolates and was first
identified in the common clinical laboratory strain PA14. PesA has been shown to
exert positive control on S3 toxin and immunity protein expression in these
clinical isolates, possibly by contributing to concurrent expression of these two
proteins, though the specific mechanism underlying this process has yet to be
elucidated [100].

Pyocins AP41 and S8
While many S-type pyocins share similarities in sequence composition, Stype pyocins AP41 and S8 have a distinctive genetic structure [80, 85, 87, 101].
AP41 genes are unique because they are located on a transposon, which has
been appropriately named TnAP41. This transposon, which is composed of 3229
base pairs, is made up of two genes encoding the killing and immunity proteins
for AP41. These two genes are located together on an operon and are flanked by
inverted repeat sequences, which are typically found on transposons; however,
this operon lacks the genes necessary for transposition, such as transposase
[101]. It has also been noted that the GC content of TnAP41 is 54.1% [101] while
the rest of the P. aeruginosa genome is 66.6% [62], which suggests that TnAP41
is a more recently acquired genetic element. In addition to TnAP41, another
transposon has recently been identified in the P. aeruginosa genome as a carrier
of a novel S-type pyocin, S8 [85]. This recently described transposon, Tn6350,
also shares homology to the Tn3 family of transposons and is comprised of eight
ORFs. These ORFs code for an ATPase, a transposase, a resolvase, pyocin S8,

23

an immunity protein, and three hypothetical remaining proteins that have yet to
be characterized [85].

Talocins – R- and F-type pyocins
In addition to the S-type pyocins, over 90% of P. aeruginosa strains
produce at least one of two types of pyocins, the R-type pyocin or the F-type
pyocin, with some strains carrying genes for both types of these pyocins [80,
102]. The R- and F-type pyocins, collectively referred to as talocins, are defective
prophages that share many physiological similarities with bacteriophage as these
pyocins can be induced by DNA damaging agents, display antimicrobial action,
and require cell surface receptors in a recipient cell to function [80]. The R-type
and F-type pyocins share homology with P2 and lambda phage, respectively,
suggesting that these pyocins are likely ancestrally derived from these
bacteriophages [83]. Both R- and F-type pyocins lack the genes responsible for
head synthesis and consequently resemble headless bacteriophage tails that
have, over time, specialized in bactericidal activity. Respectively, the R- and Ftype pyocin complexes are made up of 14 and 17 proteins, encoded in one or
more operons in a distinct gene cluster on the P. aeruginosa chromosome (Fig.
3) [83].
It is thought that, like the colicins of E. coli, R and F-type pyocins are also
released outside of the cell via lysis, but genes responsible for this process have
not yet been well-characterized [80, 83]; however, several ORFs that could
potentially encode lytic genes for pyocin release have been identified. The gene
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encoded at the PA0629 locus shows some similarity to active domains of
chitinases, a type of lytic enzyme, which indicates that a gene encoded in this
ORF may be a lytic enzyme to facilitate the release of pyocins [83]. Additionally,
the genes found at the PA0629, PA0630, and PA0631 loci in P. aeruginosa
PAO1 share homologies to phage lytic genes and, more specifically, the genes at
the PA0614 and PA0629 loci have been empirically shown to encode lytic
enzymes in laboratory studies as cell lysis was observed when these loci were
cloned into E. coli [83]. Consequently, it can be inferred that some, if not all of
these ORFs, harbor lytic genes responsible for cell lysis and release of pyocins.
Like the S-type pyocins, the talocins have multiple subtypes (R1-R5 and
F1-F3). The subtypes of both R- and F-type pyocins are similar structurally;
however, there is variation among the tail fiber composition of the subtypes,
which presumably allows for differential killing range as the tail fiber composition
is thought to account for receptor specificity [80]. The receptors for talocins are
lipopolysaccharides (LPS), which are large molecules found in the outer
membrane of Gram-negative bacteria [103, 104]. Laboratory studies have
demonstrated that R-type pyocins target the outer core component of LPS;
however, the specific LPS target for the F-type pyocin is unknown [105]. Unlike
the S-type pyocins, the talocins do not have immunity proteins, and instead,
immunity is thought to be mediated through receptor incompatibility [80].
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inflexible and have been named for the rigidity of their structure [80]. R-type
pyocins are composed of a hollow cylinder capable of contraction as well as a
baseplate and six tail fibers, which are responsible for receptor binding and target
specificity [109-111]. When the R-type pyocin binds to and makes firm contact
with the LPS of a target cell, the pyocin complex will rapidly contract and
penetrate the outer membrane [103, 112]. Once this process occurs, there will be
an arrest of macromolecule synthesis in the target cell and the intracellular
contents will be released [113]. Cell death results from pore formation and
subsequent membrane depolarization [80, 114]. R-type pyocins are highly
potent, and only one R pyocin molecule is required to kill a target cell [106].
There are five subtypes of this pyocin, R1-R5; these subtypes differ only in their
killing range, which is mediated through differences in tail fiber composition [113].
The R-type genes are located between trpE and trpG on the P. aeruginosa
chromosome. 13 ORFs (found at loci PA0616-PA0628 in P. aeruginosa PAO1)
have been identified as being involved in R-type pyocin production. These genes
encode for R-type pyocin protein subunits such as the baseplate, tail fibers, tail
tube, and tail sheath [81, 83, 115].

F-type pyocins
F-type pyocins were first identified in 1967 and are flexible non-contractile
rod-like structures and resemble flexible phage tails [116, 117]. There are three
subtypes of F-type pyocins, F1-F3, and, like those of the R-type, these subtypes
differ only in their tail fiber composition and the resulting killing range [117]. Little
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is known about the specifics of the killing mechanism of the F-type pyocin, but it
is posited that this bacteriocin also kills target cells through pore formation.
Unlike the R-type pyocins, which can kill a target cell with only one molecule, it
has been reported that the F1 pyocins must be present as 280 molecules to kill a
sensitive competitor [118]. The F-type pyocin gene cluster is located downstream
of the R-type pyocin gene cluster. 17 ORFs in this region that have been
identified as the genes potentially responsible for F-type pyocin production:
PA0632-PA0648 in P. aeruginosa PAO1 [83].
Over time, the genetic determinants of pyocins have become more wellcharacterized; however, few studies have examined genetic diversity with
respect to pyocins across different strains of P. aeruginosa, particularly in freeliving isolates. Furthermore, it is unclear if pyocin genotype can be directly linked
to phenotype. Therefore, this dissertation addresses the pyocin genetic diversity
in our environmental P. aeruginosa collection of isolates as well as the
relationship between pyocin genetic determinants and patterns of inhibition
observed in our laboratory study.

Research plan
While patterns of pyocin diversity have been studied in laboratory, clinical,
and environmental isolates of P. aeruginosa to varying degrees, the ecological,
evolutionary, and genetic mechanisms underlying this diversity in natural spatially
isolated settings requires further investigation. This dissertation attempts to
answer the following questions in regard to patterns of diversity in pyocin
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genotype and phenotype in household drain isolates of P. aeruginosa:
1.

What is the relationship between spatial scale and pyocin
inhibition/susceptibility? (Chapter 2)

2.

What is the relationship between environment of isolation and pyocin
inhibition/susceptibility? (Chapter 2)

3.

What is the relationship between resource use and pyocin
inhibition/susceptibility? (Chapter 2)

4.

What is the relationship between phylogenetic distance and pyocin
inhibition/susceptibility? (Chapter 2)

5.

What are the overall patterns of diversity in pyocin genotype of our
household strain collection? (Chapter 3)

6.

What is the relationship between spatial isolation (house) and pyocin
genotype? (Chapter 3)

7.

What is the relationship between environment of isolation (drain type) and
pyocin genotype? (Chapter 3)

8.

What is the relationship between pyocin immunity genes and inhibition?
(Chapter 3)

9.

What is the relationship between the combination of pyocin killing genes
and inhibition? (Chapter 3)

A central goal of biology is understanding the processes that generate and
maintain diversity. This research works toward this goal as it elucidates the
evolutionary, ecological, and genetic mechanisms underlying diversity in a
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system that is characterized by a profound amount of complexity. The ecological
and evolutionary processes investigated in this work may provide insights into
underpinnings of diversity in other systems of study.
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CHAPTER II
SPATIAL STRUCTURE MAINTAINS DIVERSITY OF PYOCIN INHIBIITON IN
HOUSEHOLD PSEUDOMONAS AERUGINOSA
Summary
Nearly all bacteria produce narrow-spectrum antibiotics called
bacteriocins. Studies have shown that bacteriocins can mediate microbial
interactions, but the mechanisms underlying patterns of inhibition are less well
understood. We assembled a spatially structured collection of isolates
of Pseudomonas aeruginosa from bathroom and kitchen sink drains in nine
households. Growth inhibition of these P. aeruginosa by bacteriocins, known as
pyocins in this species, was measured using pairwise inhibition assays. Carbon
source usage of these isolates was measured, and genetic distance was
estimated using multilocus sequencing. We found that as the distance between
sites of isolation increased, there was a significantly higher probability of
inhibition, and that pyocin inhibition and susceptibility vary greatly among isolates
collected from different houses. We also detected support for other mechanisms
influencing diversity: inhibition outcomes were influenced by the type of drain
from which isolates were collected, and while we found no indication that carbon
source utilization influences inhibition, inhibition was favored at an intermediate
genetic distance. Overall, these results suggest that the combined effects of
dispersal limitation among sites and competitive exclusion within them maintain
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diversity in pyocin inhibition and susceptibility phenotypes, and that
additional processes such as local adaptation and effects of phylogenetic
distance could further contribute to spatial variability.

Introduction
A central goal of evolutionary biology is understanding the underlying
mechanisms that generate and maintain diversity. One factor thought to promote
diversity in microorganisms is the production of bacteriocins, which are narrowspectrum antimicrobials produced by nearly all species of bacteria. These toxins
differ from traditional antibiotics in that their targets are presumably restricted to
members of the same species or closely related species, although there is some
diversity among the phylogenetic killing range of these toxins [51, 52, 119]. The
bacteriocins of Pseudomonas aeruginosa, called pyocins, are unique in both their
highly abundant production and diversity. For example, P. aeruginosa has the
ability to produce three different types of pyocins: S, R, and F. S-type pyocins are
similar to the bacteriocins of E. coli, called colicins, and are typically composed of
a toxin and immunity gene. On the other hand, R and F type pyocins resemble
phage tails and resistance is thought to be mediated through receptor
incompatibility [80]. Furthermore, each of these classes has multiple subtypes
and isolates have the ability to produce unique combinations of each type [55,
78, 80]. We use inhibition assays to expose the potential pyocin-mediated
interactions among environmental isolates of P. aeruginosa, that may or may not
come into contact in the field. The observation of inhibition in these assays can
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be a result of the production of any type of pyocin (S, R, and/or F) and indicates
that processes occurring in the environment contribute to the maintenance of
diversity in pyocin inhibition and susceptibility.
One process believed to maintain diversity in bacteriocins is the presence
of spatial structure in the environment, particularly when there is limited
dispersal. We investigate the capacity to inhibit among P. aeruginosa isolates
collected at varying levels of spatial separation: isolates from the same drain in a
human house, from different drains from the same house, and from different
houses in a metropolitan region. We predict a pattern of increased inhibition
outcomes as the sites of isolation become more spatial distant, based on likely
dispersal limitations among these drains and the large diversity of pyocins
described among P. aeruginosa, including among household isolates [51, 55].
We also expect little inhibition among isolates collected within the same drain,
due to the elimination of susceptible phenotypes by pyocin producers or the
evolution of resistance to pyocins encountered at the within-drain level.
Furthermore, we predict variability in inhibition across different houses due to the
stochastic nature of dispersal among sites, combined with the fact that there are
no universal optimal pyocin gene contents [53].
Another factor that can promote diversity at a global scale is local
adaptation to different environments [74]. This study focuses on isolates from
household bathroom and kitchen sink drains, as previous sampling studies have
revealed that this is where P. aeruginosa is most common in the house [73, 74].
Previous sampling studies have shown conflicting results regarding the
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differences in P. aeruginosa recovery between bathroom and kitchen sink drains,
with some studies showing P. aeruginosa to be more common in bathrooms [74]
[72] while others show no differences in recovery between drains from these
types of rooms [71, 73]. This possible difference in recovery draws attention to
the fact that environments may have differences such as the physical shape,
frequency of use, and types of inputs associated with them. Such differences
may result in differences in the relative contributions of competition versus
selection by the environment. In the context of different types of household
drains, this might result in differential exposure to one another and selection to
inhibit one another, leading ultimately to differences among drain types in their
inhabitants’ inhibition profiles. We evaluated the relationship between drain type
and recovery rate and inhibition patterns to investigate potential contributions of
local adaptation to different habitat associated with bathroom versus kitchen sink
drains.
Although there are indications that bacteriocin-mediated inhibition may not
be directly predictive of competitive outcomes [55], there are two well studied
hypotheses regarding the relationships between bacteria and whether or not
bacteriocin-mediated inhibition should be favored [12, 14, 120]. First, if
bacteriocins do contribute to the outcome of competitive interactions, it may be
that bacteriocin-mediated inhibition will occur when two individuals have similar
resource requirements, given that competition occurs over shared resources [12,
14, 120, 121]. This is because while costly production of bacteriocins is not
favored when niche overlap is minimal, it becomes more beneficial as niche
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overlap increases. As niche overlap becomes even stronger, the capacity to
inhibit the competitor may decrease not because there is insufficient benefit to
bacteriocin-mediated inhibition, but because the competitors may be similar in
their bacteriocin genotypes as well as their metabolic profiles, causing them to
lack the capacity to inhibit one another [12, 120]. As such, we predict a “humpshaped” relationship between inhibition and metabolic dissimilarity in which
inhibition is least favored among isolates with low and high resource overlap and
is most likely to occur when interacting isolates share an intermediate number of
resources. Previous studies have examined this relationship between resource
competition and bacteriocin-mediated interactions but results vary in the degree
to which they conform to this prediction [12, 14, 120].
Second, a hump-shaped relationship such that bacteriocin-mediated
inhibition is maximized when two individuals are genetically related at an
intermediate level [120] is also predicted. This is because bacteriocin production
targeting very closely related isolates will not be favored, because shared
phylogenetic history will cause closely related isolates to carry the same
bacteriocin immunity genes and therefore not be killed by their shared toxins.
Bacteriocin-mediated competition should also be minimal when two individuals
are genetically distant if, along with other traits, their resource use overlap
declines over evolutionary time. The hump-shaped relationship has been found
among laboratory and clinical isolates of P. aeruginosa by Schoustra et al. [120],
but other studies of environmental microbes have found contrasting evidence for
this relationship [12, 14, 57].
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The goal of this study was to elucidate the underlying mechanisms that
drive diversity in bacteriocin-mediated inhibition. Relationships among spatial
scale, metabolic dissimilarity, genetic distance, and bacteriocin inhibition have
been examined in different microbial systems with differing results. Furthermore,
these patterns have not yet been studied in household isolates of P. aeruginosa,
where the high production of pyocins [51, 55] suggests an important ecological
role for these protein structures. We found the lowest probability of inhibition to
be among isolates collected from the same drain and the highest probability of
inhibition to be among isolates collected from different houses, and we identified
additional substantial random variation among specific pairs of houses. No
relationship was found between metabolic dissimilarity and inhibition; however, a
significant hump-shaped relationship was found between genetic distance and
inhibition, meaning that isolates of an intermediate genetic distance displayed the
highest probability of inhibition.

Methods
Bacterial Isolate Sampling
70 houses in the Louisville, Kentucky metropolitan area were sampled
from June 2016-May 2017. Bathroom and kitchen sink drains were sampled
using a sterile cell scraper. Samples from all 70 houses were collected in sterile
1X PBS and stored at 4 C. Samples were plated onto cetrimide agar [122] and
incubated at 37 C for 24-48 hours. If growth was observed on the plate, colonies
were isolated and species-specific PCR primers were used to identify those
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colonies that were P. aeruginosa [123].
For the first 12 houses, up to 13 clonal picks were performed for each
drain sample to maximize likelihood of recovery. Based on results of this
sampling, a standardized protocol was used in sampling of houses 13-70. In
these latter houses, the minimum of all colonies on a plate or up to seven
colonies were isolated and P. aeruginosa was identified using a species-specific
PCR reaction [123].
Across all 70 houses, nine houses yielded a total of 105 isolates. All P.
aeruginosa isolated (105 isolates in all) were stored in 20% glycerol at -80 C. Of
these, three isolates were randomly chosen from each of the two drain types
(bathroom sink drain and kitchen sink drain) in all nine houses to be used in
pairwise inhibition assays. This resulted in a total of 54 P. aeruginosa isolates for
the pairwise inhibition assays.

Pairwise Inhibition Assays
The 54 (three isolates x two drain types x nine houses) isolates were
tested for ability to inhibit and resist inhibition in all pairwise combinations
according to the protocol described by Fyfe et al. [124]. Each pair was assayed
three independent times, for a total of 2916 tests of inhibition. Briefly, individual
clones of the 54 isolates were picked and used to inoculate 4 mL of LB broth.
Each culture was grown for about 18 hours at 28 C with shaking at 250 rpm.
After the initial incubation period, 10 L of this overnight culture was used to
inoculate two tubes of 4 mL LB broth. Cultures were incubated with shaking at 28
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C for 2-3 hours. Pyocin production was then induced in one culture (the
“producer” culture) using mitomycin C, a DNA damaging agent that has been
shown to induce bacteriocin expression [52, 83], to a final concentration of 2
g/uL. The second, uninduced (“indicator”) culture was also incubated alongside
the producer culture.
After 16-18 hours incubation at 28 C, 5 L of the producer cultures were
spotted onto LB plates and incubated for 6 hours at 28 C. 1.5 mL of chloroform
was added to each plate to kill the producer colonies and plates were allowed to
dry for 30 minutes. Producer colonies were killed prior to soft agar overlay to
avoid the observation of inhibition due to a mechanism other than pyocin
production, such as contact-dependent or secretion-mediated killing. In each
experimental block, the indicator cultures were standardized to the lowest
observed O.D.595 reading among the set of 54. Once standardized in this way,
100 L of each indicator culture was used to inoculate 6 mL of soft agar, which
was vortexed gently and poured over the agar surface of plates that had been
spotted with killed producer cultures. Plates were left to incubate for 16-18 hours
at 28 C. Zones of inhibition of the indicator isolates were identified by visual
inspection. Cases of inhibition presented as either a clear, defined zone of
inhibition (indicating R or F-type pyocin) or diffuse zone of inhibition (indicating Stype pyocin inhibition); both inhibition phenotypes were considered cases of
inhibition for the purposes of data collection.
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Genetic Distance
Genomic DNA was extracted from isolates using 1 mL of overnight culture
and Wizard Genomic DNA purification kit (Promega, Madison, WI, USA). Genetic
distances were estimated using Illumina whole genome sequencing and ARIBA,
[125] which was used to extract seven housekeeping genes (ascA, aroE, guaA,
trpE, mutL, nuoD, ppsA) used in a P. aeruginosa multilocus sequence typing
scheme developed by Curran et al. [126]. These genes were concatenated and
pairwise genetic distances were calculated using only the seven housekeeping
gene sequences and R package ape [127] on RStudio version 1.1.453 [128].

Resource Competition
The ability of the 54 P. aeruginosa isolates to use 31 carbon sources was
measured in triplicate using EcoPlates (Biolog, Hayward, CA, USA) and a
protocol adapted from Schoustra et al. [120]. Cultures were grown overnight to
stationary phase to a minimum O.D.595 of 0.8. Cultures were diluted by adding 10
L of overnight culture to 10 mL of minimal salt media (N2HPO4 6.8 g, KH2PO4 3
g, NaCl 0.5 g, NH4Cl 1 g, 1000 mL dH20). After a starvation period of two hours,
plates were inoculated with 150 L of sample. The O.D.595 of all wells in the plate
were measured immediately after inoculation (T0) and again after 48 hours of
incubation at 28 °C. The absorbance measures from the 48-hour time point were
used to calculate pairwise Bray-Curtis dissimilarity indices with R package vegan
[129].
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Statistical analysis
To assess the differences in recovery from bathroom and kitchen sink
drains, presence or absence of P. aeruginosa from each drain was analyzed
using McNemar’s test in the set of 58 houses, which were sampled using a
standardized sampling technique.
Four generalized linear mixed models were performed with the SAS
version 9.4 TS1M3 GLIMMIX procedure [130]. Models were run with LaPlace
estimation and containment method of denominator degrees of freedom
estimation. Self-on-self interactions were excluded from all analyses, as no
inhibition was expected or observed in these controls. The results of the three
replicate assays per pair were reduced to a dichotomous response variable,
inhibition outcome by using the most common (2 out of 3) outcome when all
three did not agree.
We examined the importance of spatial scale by running a generalized
linear mixed model with inhibition as a binary response variable and spatial scale
as a categorical predictor variable. House of isolation was not included in this
model as a predictor variable because it is confounded with spatial scale, but
was evaluated in all other models. This was done by including the house of the
producer, the house of the indicator, as well as the interaction between the two
as random effects. We also tested the effect of drain type by running a
generalized linear mixed model with inhibition as a response variable and
producer drain type, indicator drain type, and the interaction between the two
terms included as fixed predictor variables.
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We explored the hump-shaped relationship between metabolic
dissimilarity and inhibition by running a generalized linear mixed model with
metabolic dissimilarity and the square of metabolic dissimilarity as predictor
variables and call as the response variable. Similarly, we ran a generalized linear
mixed model using genetic distance and the square of genetic distance as
predictor variables and call on inhibition as the response variable.

Results
P. aeruginosa is rarely found in multiple drains within a house
The bathroom and kitchen sink drains of 70 houses were sampled in the
Louisville KY Metropolitan area. 58 of these 70 houses were sampled using a
standardized sampling protocol; this subset of houses was used for analysis of P.
aeruginosa recovery. Of these 58 houses, 22 yielded P. aeruginosa from at least
one drain with an overall recovery of roughly 37%. P. aeruginosa was collected
from the bathroom sink drain only in 11 houses (19%), from the kitchen sink in
only five houses (9%), and from both the bathroom and kitchen sink drain in six
houses (10%). Despite slightly higher recovery from bathroom sink drains than
from kitchen sink drains, this analysis identified no significant difference in
recovery from the two drain types (p=0.21, McNemar’s Test).

Inhibition varies across space
We tested an isolate’s ability to inhibit using an agar overlay method from
a well-established protocol [124], which uses the DNA damaging agent
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mitomycin C, to induce bacteriocin expression. Pairwise interactions were
conducted, meaning that each isolate was examined as both a “producer” and as
an “indicator.” As a producer, an isolate was treated with mitomycin C and was
tested for its ability to kill a non-induced strain, termed the indicator. Although the
presence of pyocins was not directly confirmed during the inhibition assays, the
presence of pyocin genes within the isolates used in these assays was confirmed
comparison to the with BAGEL database [131](A.A.M., unpublished data).
Additionally, zones of inhibition observed in the assays presented as diffuse or
clear zones of inhibition, and did not present as plaques that would be expected
if bacteriophage was responsible for killing. Previous studies have also
repeatedly shown that an induction with mitomycin C is a reliable method to
induce the expression of pyocin genes [52, 83]. Additionally, no cases selfinhibition were observed in the assays, suggesting that pyocins indeed were
responsible for the zones of inhibition as each isolate should carry an immunity
gene to its own toxin [132].
Self-on-self interactions, as expected, never resulted in inhibition (white
squares, Fig. 4). Of the remaining 2862 pairwise interactions, overall, 944 (33%)
resulted in inhibition. The interactions in this study were observed across three
spatial scales: within the same drain, between different drains in the same house,
and across different houses. No inhibition was observed between isolates
collected from the same drain (dark grey squares, Fig. 4). Inhibition was
observed among isolates collected from different drains in the same house in
three of nine houses (dark green squares). The majority of inhibition was

42

observed among isolates collected from different houses (dark blue squares). A
generalized linear mixed model assessing dependence of the outcome of the
inhibition assay on spatial scale showed that as distance increased, there was a
significantly higher probability of inhibition (Fig. 5, p<0.0001; Table 1).
We also examined patterns of pyocin inhibition and susceptibility among
isolates collected across different houses through the inclusion of house as a
predictor variable in generalized linear mixed models with metabolic and genetic
distance. We found significant variability attributable to both the house of the
producer and the house of the indicator. In other words, whether or not a
producer is able to inhibit an indicator depends on the house of isolation for both
interacting isolates (Fig. 4). Therefore, these results suggest that, in addition to
scale, there is random stochasticity across space that contributes to diversity in
pyocin phenotype.
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Figure 4. Pairwise inhibition assay outcomes. Light grey boxes with letters
represent the nine houses from which bathroom and kitchen sink isolates were
collected. Yellow and orange boxes represent isolates obtained from bathroom or
kitchen sink drains, respectively. Pairwise interaction assay results were color
coded based on a call on the outcome of inhibition, which was made if two out of
three interactions resulted in inhibition. White squares represent no selfinhibition. Dark blue squares represent inhibition among isolates collected from
different houses. Dark green squares represent inhibition among isolates
collected from the same house and dark grey squares represent no inhibition
observed among isolates collected from the same drain. Cases of non-inhibition
across houses are indicated in light blue and cases of non-inhibition between
drains of the same house are indicated in light green.
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Figure 5. Predicted probability of inhibition when isolates are collected at
different spatial scales. Least-squares means with 95% confidence intervals
display the predicted probability of the producer isolate to inhibit the indicator
isolate. Different letters indicate significant differences in means at alpha=0.05
after correcting for multiple comparisons using the Tukey-Kramer adjustment.
Table 1. Mean percentage of inhibition across scale.

Scale

Mean percentage of inhibition

Within a drain

0

Between drains

23.5 %

Across houses

34.9 %
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Inhibition varies with drain type
Previous studies have shown that bathroom and kitchen sink drains often
differ in their recovery of P. aeruginosa [72, 74]. Based on these differences in
recovery between drain types, we hypothesized that isolates collected from
different drain types may differ with respect to their pyocin inhibition or
susceptibility. To address this, pyocin inhibition was measured across two
different household drain types: bathroom sink drains and kitchen sink drains. A
generalized linear mixed model was run with producer drain type, indicator drain
type, and the interaction between these two terms as fixed effects. We found that
the inhibition observed was strongly affected by the particular combination of
drain types from which the producer and indicator isolates were obtained
(interaction effect, p=0.05). In particular, when indicators from kitchen sink drains
were challenged with producers from bathroom sink drains, significantly less
inhibition occurred in comparison to interactions between any other combination
of isolation sources, and none of the other combinations resulted in differences in
inhibition (Fig. 6). The detection of overall greater capacity to inhibit and greater
resistance to being inhibited among kitchen sink isolates (producer main effect,
p=0.0248, indicator main effect, p=0.0026) is likely driven by this single
combination of drain types.
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Figure 6. Predicted probability of inhibition within isolates collected from different
drain types. Predicted probabilities of inhibition are least-squares means with
95% confidence intervals. Different letters indicate significant differences in
means at alpha=0.05 after correcting for multiple comparisons using the TukeyKramer adjustment.

Metabolic dissimilarity does not predict inhibition
To determine if metabolic dissimilarity is an important predictor of the
outcome of inhibition, we measured resource use of 31 different carbon
resources using EcoPlates (Biolog, Inc., Hayward, CA, USA) and calculated
pairwise metabolic dissimilarities. We then ran a generalized linear mixed model
with inhibition as the response variable and metabolic dissimilarity and the
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square of metabolic dissimilarity as predictor variables (Table 2). Neither
metabolic dissimilarity nor its quadratic term was found to be significant in the
model (p=0.4905 and 0.7486, respectively). Therefore, we found no evidence of
a hump-shaped relationship between metabolic dissimilarity and inhibition. These
results indicate that competition mediated by differential use of these common
carbon sources may not play an important role in determining the outcomes of
inhibitory interactions.

Table 2. Generalized linear mixed model testing the effect of metabolic
dissimilarity and the square of metabolic dissimilarity as well as various random
effects on the outcome of inhibition.
Effect

Estimate

DF

Test Statistic⨥

Metabolic Dissimilarity

2.5926

2515

0.48

Metabolic Dissimilarity2

2.6765

2515

0.1

Producer House

0.2240

0.76

Indicator House

0.9343

1.47

Draincomboordered

0.03819

0.1611

Producer House*Indicator House

2.4890

3.89***

⨥Fixed effect is tested with an approximate F test. Random effects are tested using Wald Z tests.
* 0.01 < p < 0.05
** 0.001 < p < 0.01
*** p < 0.001

Genetic distance has a hump-shaped relationship with inhibition
To determine if genetic distance has a hump-shaped relationship with
inhibition, we measured genetic distance using differences among isolates’
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sequences at seven housekeeping genes in the P. aeruginosa genome. We
looked to see if inhibition occurs most frequently at an intermediate genetic
distance by running a generalized linear mixed model with inhibition as the
response variable and genetic distance and the square of genetic distance as the
predictor variables (Table 3). This model identified a significant positive value for
the parameter estimating the linear effect of genetic distance (p<0.0001) and fit a
negative parameter estimate for the effect of the square of genetic distance
(p=0.0006). These estimates model the predicted hump-shaped relationship for
genetic distance and bacteriocin-mediated interactions in which these
interactions are predicted to occur most frequently when two isolates are
intermediately genetically related (Fig. 7).

Table 3. Generalized linear mixed model testing the effect of genetic distance
and the square of genetic distance as well as various random effects on the
outcome of inhibition.
Effect

Estimate

DF

Test Statistic⨥

Genetic Distance

308.18

1871

17.84***

Genetic Distance2

-17798

1871

11.97***

Producer House

0.2110

.

Indicator House

0.9595

1.40

Draincomboordered

0.05152

.

Producer House*Indicator House

2.2006

3.89***

⨥Fixed effect is tested with an approximate F test. Random effects are tested using Wald Z tests.
* 0.01 < p < 0.05
** 0.001 < p < 0.01
*** p < 0.001
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Figure 7. Predicted probability of inhibition with genetic distance. The line is
plotted using estimates from the generalized linear mixed model run to examine
the effect of genetic distance and the square of genetic distance on the outcome
of inhibition. Points represent frequency of inhibition for each measure of genetic
distance, calculated by averaging call on the outcome of inhibition among all
interacting isolates of a particular genetic distance.

Discussion
P. aeruginosa is not ubiquitous in household drains
In this study, we found a greater percentage of drains containing P.
aeruginosa than in previous sampling studies done by our group (37% as
opposed to 15 and 28%) [73, 74]. The sensitivity of detection of P. aeruginosa
was expected to be higher than in similar studies, for two reasons. The culture-
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based sampling employed the more species-specific medium cetrimide rather
than Pseudomonas Isolation Agar [122], and more isolates were collected per
sample taken. However, despite our intensive sampling focused on the single
type of site in the house where P. aeruginosa has previously been shown to most
frequently inhabit, and despite higher recovery in this study from each drain type
than in those previous studies, we found that the proportion of houses from which
P. aeruginosa was recovered from both bath and kitchen sink drains was still
relatively low (10%). This suggests that, in addition to dispersal into the house,
within-house forces such as dispersal limitation or selective differences between
bathroom and kitchen sink drains limit the distribution of this species. This is
notable in part because it runs counter to the traditional characterization of this
species as a ubiquitous generalist [62, 133].

Inhibition increases with scale and varies with house
In our assays, we found that inhibition increases with the separation in the
isolation sites of the producer and indicator (Fig. 2). This suggests that the
selective pressure from pyocin producing isolates of P. aeruginosa may have
eliminated diversity with respect to this phenotype at the within-drain level.
Isolates within the same drain have either co-evolved as to not be susceptible to
the particular pyocins being produced within a single drain, or pyocin sensitive
isolates have been competitively excluded by producer isolates. In contrast,
isolates taken from different houses that were less likely to have interacted,
showed greater diversity in pyocin phenotypes, and were able to inhibit one
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another. The positive relationship among inhibition and increasing spatial scale is
consistent with those of previous studies in Pseudomonas fluorescens and in
species of the Xenhorhabdus genus [12, 57]. Although, this trend was not
observed among soil pseudomonads by Kraemer et al. [14], the scale on which
the isolates were collected in that study may have been too large to detect a
relationship with inhibition. Unlike studies done in other Pseudomonas species
and species in the Xenhorhabdus genus [12, 14, 57], we found a much higher
frequency of inhibition among isolates overall, which is likely explained by the
highly abundant production of pyocins in P. aeruginosa, and particularly in
environmental isolates of P. aeruginosa [51, 55].
Previous studies have shown that spatial structure in microbial populations
may lead to a decrease in local population diversity, but an increase in overall
diversity across larger spatial scales [12, 14, 57]. In laboratory strains of
Escherichia coli, it has been demonstrated that in unstructured environments
such as a broth culture, bacteriocin production will lead to a decrease in diversity
as one strain will competitively exclude the other. However, in a structured
environment such as that of an agar plate, competitive interactions occur more
locally, which allows for the coexistence of multiple bacteriocin phenotypes [34].
Similarly, Inglis et al. [54] also found that a pyocin producing strain of P.
aeruginosa has increased fitness relative to a non-pyocin producer under
conditions of local competition. This is because, when competition is localized,
individuals that are genetically related to the bacteriocin producer are close by
and are likely to benefit as bacteriocin production frees up resources. High rates

52

of dispersal, however, will cause competition to occur more globally and
bacteriocin production will provide less of a fitness benefit. Based on the results
of our sampling study, it appears that P. aeruginosa dispersal among houses,
and, to a lesser extent, within the houses, could potentially be limited. Moreover,
even accounting for differences among drain type, metabolic similarity, and
genetic distance, significant variability in pyocin phenotype was detected among
P. aeruginosa isolated from different houses. This further supports our
conclusion that dispersal limitations across different houses leads to the
maintenance of diversity in inhibitory interactions. Further investigation into the
relationship between highly patchy environments, like the built environment, and
diversity in bacteriocin inhibition in this species and others is warranted.

Local adaptation to drain type may influence inhibition
Previous sampling studies have yielded varying results regarding the
difference in P. aeruginosa recovery from bathroom and kitchen sink drains, with
either greater recovery from bathroom drains [72, 74] or no differences detected
[71, 73]; our study showed a non-significant trend toward greater recovery in
bathroom drains. In evaluating possible differences in the outcome of inhibition
assays with respect to isolates’ house drain types, we observed differences in
the pyocin inhibition and sensitivity profiles. We found that inhibition assay
outcomes depended on the drain types of interacting isolates. This suggests that
local adaptation to drain type may be at play and responsible for differences in
the competitive interactions among those isolates.
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While we have not explored the particular ecological differences between
bathroom and kitchen sink drains, there may be both abiotic and biotic
components of these drain types that could contribute to local adaptation of P.
aeruginosa isolates. For example, there could be differences in available
resources or in microbial community compositions, either of which could affect
selection through competitive interactions among P. aeruginosa. Future studies
in this area could work to clarify the differences in drain types with respect to both
abiotic and biotic factors.

Resource competition does not drive inhibition
We looked for differences in resource use among isolates to test the
prediction that resource dissimilarity may help predict inhibitory interactions [12,
14, 120], but found no evidence of such a relationship. Schoustra et al. [120]
observed the frequency of inhibition to peak at intermediate resource usage
overlap among clinical and laboratory P. aeruginosa isolates. Differences
between our results and that study could be due the fact that we used only
environmental isolates, not clinical isolates and laboratory strains. Kraemer et al.
[14] found metabolic dissimilarity to negatively correlate with frequency of
inhibition, while Bruce et al. [12] similarly found that inhibition was significantly
higher between isolates with greater niche overlap, suggesting that competition
for shared resources may play an important role in the selection for and
maintenance of bacteriocin production. This could occur if outcompeting other
isolates with similar resource requirements through bacteriocin production
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liberated limited resources and provided the bacteriocin producing strain with a
competitive advantage. The differences between the findings in our study and the
outcomes of Bruce et al. [12] and Kraemer et al. [14] could be attributed to the
fact that Kraemer et al. [14] were likely examining relationships among different
Pseudomonas species rather than within one species, and Bruce et al. [12]
calculated niche overlap as opposed to metabolic dissimilarity as we did.
Although we detected no significant relationship between metabolic dissimilarity
and pyocin inhibition profile, we note that there are many ways in which resource
similarity could differ among isolates that would not be detectable in our assay,
particularly in light of the known metabolic versatility of P. aeruginosa [62].
Additionally, the carbon resources in Biolog EcoPlates are biased toward
plant-based carbon sources, which are likely different from the carbon sources
available in sink drains. Future work addressing metabolic similarity could
explore other resources over which competition might be occurring such as
alternative carbon sources, nitrogen sources, and other bacterial nutritional
requirements that might be more available to isolates in sink drains. It can also
be noted here that Bara et al. [55] found that the ability to inhibit another isolate
via pyocin production does not always predict overall competitive ability, so it is
possible that pyocin inhibition does not play a critical role in competition and
therefore is unrelated to resource use. As such, future investigation into the
specific ecological functions of pyocins could further illuminate the maintenance
of these antibiotics in microbial populations.
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Inhibition is most favored at an intermediate genetic distance
We examined the relationship between genetic distance and patterns of
inhibition among the isolates in this study and found strong evidence to support a
hump-shaped relationship. These results are consistent with the predicted humpshaped relationship that was observed by Schoustra et al. [120], though not with
those of Hawlena et al. [57], Kraemer et al. [14] and Bruce et al. [12], which
examined such relationships among more distantly related taxa and used
different approaches to measuring genetic distance.
Because the measure of genetic distance that we used is based on
sequence comparison of conserved housekeeping genes, it measures genetic
similarity based on phylogenetic history, and is not mechanistically driven by
selection on pyocin use. We know that bacteriocin production in P. aeruginosa,
particularly in household isolates [55], is much more common than that of other
Pseudomonas and bacterial species [51]. Thus, the hump-shaped relationship
between this form of genetic distance and inhibition patterns could be caused by
widespread use of pyocins and restricted movement in space, which shape the
population genetic structure of this species. We note that other measures of
genetic distance could reveal additional evolutionary dynamics affecting patterns
of pyocin interactions. For example, a decline in killing at greater genetic distance
can occur if more genetically distant bacteria lack the particular cell surface
receptors required for bacteriocin binding [95, 105, 132]. Such patterns would be
better detected using measures of genetic distance based on gene content or
gene sequence of pyocin associated genes such as toxin, immunity, regulatory,
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and receptor synthesis genes. Use of such different genetic distance measures
might not reveal the hump-shaped relationship that we detected with our
measure.

Conclusion
In this study, we explored many potential driving forces of diversity in
pyocin-mediated inhibition using isolates collected from spatially structured
bathroom and kitchen sink drains across nine different houses. Differences in the
outcome of inhibition among isolates from different drain types and among
isolates differing in their genetic distance suggest roles for local adaptation
and/or limited local dispersal, and a signature of phylogenetic history in
maintaining pyocin diversity. However, we also found strong patterns indicating
an important role for dispersal limitation at a landscape level in driving patterns of
pyocin-mediated inhibition. When combined with competitive exclusion within a
drain, dispersal limitation can explain an increase in inhibition with spatial scale
and random house-to-house variation in patterns of inhibition.
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CHAPTER III

GENETIC PATTERNS OF PYOCIN DIVERSITY IN HOUSEHOLD
PSEUDOMONAS AERUGINOSA
Summary
Bacteriocins are narrow-spectrum antibiotics, meaning that the killing capacities
of these antimicrobials are typically restricted to the same species or closely
related species. Pseudomonas aeruginosa, a Gram-negative opportunistic
pathogen, is characterized by the diverse and abundant nature of putative
bacteriocin genes found in this species, called pyocins in this system. Diversity in
pyocin gene content has been reported in clinical isolates of P. aeruginosa,
particularly in those isolated from individuals with Cystic Fibrosis (CF), but
patterns of diversity in pyocin gene content, as well as the ecological and
evolutionary underpinnings of these patterns, is not well-characterized in
environmental isolates. Furthermore, it is unclear how pyocin genes contribute to
outcomes of inhibition. We sequenced genomes of 46 isolates collected from
bathroom and kitchen sink drains across eight houses and searched the
genomes for 11 well-characterized pyocin genes. We previously examined
pyocin inhibition among these isolates using pairwise inhibition assays. We found
that isolates across houses differed primarily with respect to immunity
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genes while isolates collected from bathroom sink drains encoded significantly
more pyocin genes than those collected from kitchen sink drains. We also found
that isolates carrying immunity genes were less likely to be inhibited and that
isolates carrying only R-type pyocin killing genes had the highest likelihood of
inhibition. These findings suggest that current environmental conditions in
different drain types and, to a lesser extent, spatial isolation across houses
contribute to differences in pyocin gene content. Furthermore, while some
patterns of inhibition can be related to pyocin genotypes in interacting isolates,
there are likely more factors in this complex system contributing to these
observed patterns including differential expression of pyocin genes and
alternative mechanisms of resistance.
Introduction
Bacteriocins are highly-prevalent narrow-spectrum antibiotics, meaning
that the killing capacities of these proteinaceous antimicrobials are typically
restricted to the same species or closely related species [48]. The bacteriocins
of Pseudomonas aeruginosa, called pyocins, are chromosomally encoded and
can be distinguished from other bacteriocin systems due to the high abundance
of pyocin genes in this species, as nearly all strains of P. aeruginosa carry genes
for at least one pyocin. Additionally, these antimicrobials are highly diverse and
composed of three types: S, R, and F. The S-type pyocins share homology to the
system of bacteriocins in Escherichia coli in that these antimicrobials are
composed of two genes: one gene encoding a protein responsible for killing
activity and one gene encoding a protein that binds to an inactivates the killing
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protein, thus providing immunity for a producing cell as well as potential target
cells [80, 86]. S-type pyocins must bind to cell surface receptors and be
translocated into a target cell for the killing activity to occur [103]. The receptors
for many S-type pyocins are receptors for iron-binding molecules called
siderophores [93-95, 102, 134]; in addition to the presence of a cognate immunity
gene, it is thought that resistance to S-type pyocins may also come from receptor
alteration such that the pyocins can no longer bind. While it is presumed that the
immunity protein is needed for a producer cell to have protection against its own
pyocin activity, previous studies have found many occurrences of “orphan” genes
in which either killing or immunity genes are present singly [55, 88]. Due to the
presence of these so-called “orphan” genes, and in particular, those instances in
which killing genes are present alone, it is unclear if pyocin immunity genes
always provide immunity to a target cell and if immunity genes are essential for a
cell to be resistant to an associated killing protein.
R- and F-type pyocins, collectively referred to as talocins, are ancestrally
derived from bacteriophage; when produced, these pyocins are multi-subunit
protein complexes that resemble headless phage tails [83]. Like the S-type
pyocins, the talocins target specific receptors on the surface of a target cell;
however, for the talocins, these receptors are lipopolysaccharides (LPS) [104,
105]. Unlike S-type pyocins, talocins act through pore formation, leading to
membrane depolarization in a target cell. Talocins are not accompanied by
immunity genes, and instead, resistance is mediated through receptor
incompatibility due to differences in LPS composition. There are 5 R-subtypes

60

(R1-R5) and 3 F-subtypes (F1-F3) that differ only with respect to tail fiber
composition, which accounts for receptor specificity and, therefore, the killing
spectra of these pyocins. The genes encoding R- and F-type pyocin structural
proteins are located together in the P. aeruginosa genome between two
genes: trpE (anthranilate synthase component I) and trpG (anthranilate synthase
component II) in the genome. Within this region, there are
genes, prtR and prtN, which encode regulatory proteins and are involved in the
expression of pyocin genes [83]. PrtR is a protein that acts as a repressor for
pyocin expression under normal conditions, and PrtN is a protein that serves as
an activator of pyocin expression under stressful conditions such as those
involving low nutrients or the presence of a mutagenic agent [81, 82]. The S-type
pyocins are located elsewhere in the genome, often near the toxA gene
(encoding exotoxin A) [89]; however, it is predicted that the expression of S-type
pyocin genes is also regulated by the same system as that of R and F-type
pyocins [81]. Also located within the R/F gene cluster are a group of putative
genes that are believed to encode lytic enzymes, which would enable cells
producing pyocins to release these antibiotics in the presence of target cells [83].
Previous studies have found evidence that R-type pyocins may play a
significant role in mediating the outcomes of inhibitory interactions in laboratory
settings [135]. However, the vast majority of these studies focus on pyocinmediated interactions among clinical isolates and, because P aeruginosa causes
chronic lung infections in individuals with cystic fibrosis (CF) [60], the most
commonly studied clinical isolates are derived from these infections. The
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contribution of R-type pyocins to the outcomes of inhibitory interactions in nonclinical isolates of P. aeruginosa has not been extensively investigated. We
anticipate that the roles of R-type pyocins could differ from those previously
reported based on phenotypic and genotypic differences in environmental and
clinical isolates. Furthermore, it is also of interest to detect patterns of inhibition
among isolates concurrently producing different combinations of pyocin killing
genes, as this has not yet been investigated and should be of particular
relevance because a large proportion of P. aeruginosa isolates have been found
to carry multiple pyocin genes.
We sequenced 46 genomes from a collection of P. aeruginosa isolates
derived from eight different spatially isolated households in the Louisville, KY
metropolitan area and searched the genomes for pyocin genes. The spatial
structure of the isolate collection allowed us to investigate the influences of
historical processes such as dispersal limitations. Additionally, these isolates
were collected from bathroom and kitchen sink drains, which provided a
collection comprised of isolates likely experiencing different abiotic and biotic
conditions, allowing us to explore the effects of contemporary conditions on
pyocin diversity. The pyocin-mediated killing patterns were previously described
[136]. The first aim of this study was to characterize overall diversity in pyocin
gene content among isolates in our strain collection and to elucidate the
mechanisms underlying this diversity. The second aim of this study was to
uncover the relationship between pyocin genotype and the outcome of inhibitory
interactions. We predicted that producer isolates carrying higher numbers of
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pyocin killing genes would have a higher likelihood of inhibition than isolates
carrying fewer killing genes. We also hypothesized that indicator isolates carrying
immunity genes would have a lower likelihood of being inhibited when compared
to isolates that do not carry immunity genes.
We found that isolates from different houses differ primarily with respect to
the total number of immunity genes found in each isolate, but do not significantly
differ in the total number of all pyocin genes, suggesting a weak relationship
between historical events and pyocin gene content. Isolates collected from
bathroom sink drains encoded significantly more killing and immunity genes,
indicating that the current conditions, either abiotic or biotic, may play an
important role in shaping patterns of diversity in pyocin genetics. Finally, isolates
with S-type immunity genes have a significantly lower probability of being
inhibited by S-type killing proteins, and isolates producing only R-type pyocins
exhibit the highest likelihood of inhibition than all other killing gene combinations.
While pyocin genotype was found to be an important predictor in the outcome of
inhibition, pyocin killing and immunity genes alone do not account for the
variability in inhibitory interactions, and we hypothesize that other factors such as
receptor specificity and gene expression further contribute to patterns of
inhibition.

Materials and Methods
Strain collection
The bathroom and kitchen sink drains of 70 households in the Louisville,
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KY metropolitan area were sampled from June 2016-May 2017. The methods for
sampling and P. aeruginosa identification were performed as described in a
previous study [136]. Strains were maintained in LB unless otherwise noted.
Pairwise inhibition assays were previously reported in [136].

Pyocin inhibition assays
Of the 105 P. aeruginosa isolates, three isolates were randomly selected
from each drain, resulting in a total number of 54 isolates used in the inhibition
assay (nine houses x two drains x three isolates). Three biological replicates of a
54x54 pairwise inhibition assay were performed according to previously
described methods [136].

Genetic analyses
Purified DNA was obtained from P. aeruginosa isolates grown overnight at
37°C in LB broth using the Wizard Genomic DNA Purification Kit (Promega,
Madison, WI, USA). Paired-end Illumina sequencing was performed on 46 of the
54 isolates in our strain collection at the Roy J. Carver Biotechnology Center at
the University of Illinois Urbana-Champaign on an Illumina MiSeq machine.
Trimmomatic [137] was used to trim raw reads, and SPAdes [138] was used to
assemble the genomes. Default settings were used for both trimming and
assembly.
The website http://pseudomonas.com [139] was used to retrieve all
putative pyocin gene sequences of interest in this study (Appendix, Tables 4 &
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5). CLC Genomics Workbench (Qiagen, Germantown, MD, USA) was used to
create a custom BLAST database of the genome assemblies in this study. A
tblastx was performed to search for complete pyocin gene nucleotide sequences.
Default settings for tblastx were used. The statistical significance threshold used
was 10; the scores for a nucleotide match and penalty for a nucleotide mismatch
were 1 and -2, respectively. To confirm the accuracy of the BLAST results,
publicly available genomes (Appendix, Tables 4 & 5) reported in the literature to
harbor specific pyocin genes of interest were added to the custom BLAST
database along with the genomes in our collection and served as reference
genomes.
Genomes were screened for S-type pyocins S1, S2, S3, S5, and AP41
(Appendix, Table 4). To determine if an R or F-type pyocin was present in our
genomes, the sequences of all annotated genes between trpE and trpG in the
genome of PAO1 [62] (Appendix, Table 5), which is known to carry genes for
both R and F type pyocins, were used as query sequences in BLAST searches of
our genomes. R-type pyocin genes were considered present if an isolate was
found to have nucleotide sequences annotated with the locus tags PA0616PA028, which are putative genes in PAO1 that encode for structural components
of R-type pyocins. It should be noted that isolates carrying R pyocin genes
differed at locus PA0621, which is logical as this gene is presumed to encode for
tail fiber proteins, which vary across different R-type pyocin subtypes. F-type
pyocin genes were considered present if an isolate was found to have nucleotide
sequences annotated with the locus tags PA0632-PA040, which are putative
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genes in PAO1 that encode for structural components of F-type pyocins
(Appendix, Fig. 8). Genes with the locus tags PA0643-PA0648 are believed to
encode tail fiber proteins and, as such, sequences are variable in this region.
Genes were considered present if the hits in our set of genomes mirrored those
of the reference genomes, which have been reported in the literature to carry
particular pyocin genes. For all genes considered present, the percent identity,
which represents the percentage of identical residues between the query and hit
sequence, was at least 94% and the sequence overlap, a percentage value for
the overlap of the query sequence and hit sequence, was at least 80%. If a gene
was considered present, it was coded in the dataset as “1,” and if a gene was
considered absent, it was coded as “0.”

Statistical analyses
All analyses were performed in R Studio Version 1.3.959 [128]. R package
emmeans [140] was used to calculate estimated marginal means from the
generalized linear models.
Two generalized linear mixed models (GLMER) were used to assess the
differences among houses with respect to the total number of pyocin genes
encoded in each isolate. The total number of pyocin killing genes, immunity
genes, and total number of genes (killing + immunity) were calculated for each
isolate. The sum of pyocin genes was a categorical response variable, house
was used as a categorical predictor variable, and drain type was included as a
random effect. The model for the total number of immunity genes did not
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converge when drain type was included as a random effect so it was dropped
from this analysis, and a generalized linear model (GLM) was used. The Poisson
distribution was used in all of these analyses.
Three generalized linear mixed (GLMER) models were used to assess the
differences among drain types (bath versus kitchen) with respect to the number
of pyocin killing genes, immunity genes, or the total number of pyocin genes
(killing + immunity). The sum of pyocin genes was a categorical response
variable, drain type was a categorical predictor variable, and house was included
as a random effect. The Poisson distribution was used in the analyses.
To assess whether the presence of an S-type immunity gene contributed
to the outcome of inhibitory interactions among our isolates, we subset the data
such that all inhibitory interactions included only cases in which the producer
isolate carried a single S-type pyocin killing gene; this included isolates carrying
an S1 killing gene and isolates carrying an S2 killing gene. None of the isolates in
our study were found to encode a single S-type pyocin gene without also carrying
talocin genes and, due to this, the producer isolates used in this dataset carried
either S1 and R-type pyocin genes, S2 and F-type pyocin genes, or S2 with Rand F-type pyocin genes. A call was made on the outcome of inhibition based on
the results of the triplicate assays performed. If at least two out of three
interactions resulted in inhibition, then a call of inhibition was made and coded as
“1.” If one or no interactions resulted in inhibition, then a call of no inhibition was
made and coded as “0.” Self-on-self interactions were excluded from the analysis
because, as expected, none of these interactions resulted in a case of inhibition.
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A generalized linear mixed model was run using call on the outcome of
inhibition as a binary response variable with the presence or absence of an S1S2
immunity gene in the indicator isolate as a binary predictor variable, “1” meaning
an S1S2 immunity gene was found to be present in the genome of the indicator
and “0” meaning the gene was determined to be absent. House of the producer
and house of the indicator were included as random effects in the model. The
model would not converge when the interaction between these two random
effects was included and, as such, the interaction was dropped from the analysis.
Inclusion of drain type of the producer isolate or drain type of the indicator isolate
did not significantly improve the fit of the model, and therefore, these terms were
also dropped from the analysis. The binomial distribution was used in this
analysis.
To investigate differences in inhibitory capacity among isolates carrying
genes encoding different combinations of pyocins, we subset the data such that
all inhibitory interactions included cases in which the indicator did not carry any
S-type immunity genes (S1/S2, S3, S5, AP41) as we were only interested in the
effect of killing gene combinations on the outcome of inhibition. First, to examine
the relative contributions of each of the pyocin types (S, R, and F) to the outcome
of inhibition, we ran three generalized linear mixed models with call on the
outcome of inhibition as a binary response variable and presence of at least one
S-type pyocin gene, presence of an R-type pyocin gene, or presence of an Ftype pyocin gene as categorical predictor variables. House of the producer
isolate and house of the indicator isolate were included as random effects. The
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binomial distribution was used in all three of these analyses.
Then, to assess the differences in inhibition capacity among isolates
carrying combinations of pyocin killing genes, we created a variable that
encompassed each of the seven pyocin killing gene combinations found in our
isolate collection: R, S2-F, S1-R, S1-S5-R-F, S1-AP41-R, S2-R-F, and S3-R-F.
T. A generalized linear model was run with call on the outcome of inhibition as a
binary response variable and pyocin killing gene combination as a categorical
predictor variable. Variables defining the house of the producer isolate and the
house of the indicator isolate were included as random effects. The interaction
between these two terms did now allow for convergence of the model so it was
dropped from our analysis. Drain type of the producer and drain type of the
indicator did not significantly contribute to the fit of the model, and therefore,
these terms were dropped from the analysis. The binomial distribution was used
in this analysis.

Results
We previously assembled a collection of P. aeruginosa isolates from
spatially structured sink drains with three isolates from each bathroom drain, and
three isolates from sink drains for each of the eight houses in the study. We used
whole genome sequencing of these isolates to search for genes encoding with Stype pyocin and immunity proteins. The genomes of each isolate were also
probed for R- and F-type pyocins often found between the trpE and trpG genes in
the P. aeruginosa genomes (Appendix, Fig. 8). Approximately half the isolates
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had seemingly intact R- and F-type pyocin loci, while the remaining 50% did not.
All isolates were found to encode PrtR and PrtN, the repressor and activator,
respectively, responsible for pyocin gene expression [81, 82]. With this summary
of pyocin gene content, we sought to identify patterns of diversity based on these
pyocin genotypes.

Overall patterns of diversity in pyocin genotype
We searched whole genome sequences of 46 P. aeruginosa isolates in
our study for complete nucleotide sequences of 11 currently described pyocin
genes. Overall, the isolates in our collection were found to carry, on average,
2.67 pyocin genes with killing and immunity gene averages of 2.15 and 0.52,
respectively. We calculated the percentage of the isolates in our collection found
to carry each gene (Fig. 9A). We then examined the complete pyocin genotype of
each isolate with respect to the pyocin genes examined in this study including Stype pyocin killing and immunity genes as well as genes of the talocins, R and F
(Fig. 9B). We found that all 46 isolates in this study carry at least one pyocin
gene, with a large number (76% or 35/46) carrying more than one gene. We
found the R-type pyocin to be the most commonly found gene as it appeared in
63% (29/46) of our isolates, followed by the F-type pyocin, which was found in
56.5% (26/46) of our isolates. S2 pyocin, S1 pyocin, and S1/S2 immunity
proteins were the next most commonly found pyocin genes with percentages of
43.5, 32.6, and 32.6, respectively. In contrast, the rest of the pyocin killing and
immunity genes (S3, S5, and AP41) were found at much smaller frequencies
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(3/46 or 6.5% for all). Overall, 82.6% (38/46) of the isolates carried at least one
S-type pyocin, and all isolates (46/46) carried at least one talocin. We note that
all strains carrying a gene encoding a S-type pyocin also carry a gene encoding
the cognate immunity protein except for strains with genes bearing S2 pyocins.
We found seven unique gene combinations of pyocin killing and immunity
genes (Fig. 9B). The highest percentage of strains carried genes encoding for
the S2 and F-type pyocin (17/46 strains or 37% of isolates). This gene
combination was followed by isolates encoding S1 pyocin, S1/S2 immunity
protein, and R-type pyocin (9/46 or 19.6%) and isolates only encoding an R-type
pyocin (8/46 or 17.4%). The remaining pyocin genotypes were found in three of
the 46 isolates in this study (6.5%). Notably, while pyocins S1, AP41, S3, and S5
are always found along with their cognate immunity genes, the S2 pyocin never
appears with its associated immunity protein, S1/S2 immunity protein.
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Figure 9. Diversity in pyocin gene (A) and genotype (B) among the isolates in
our study. Percentages of isolates in our collection carrying each of the 11 pyocin
genes (A) and percentages of isolates in the study carrying each of the pyocin
genotypes (B). S1S2I, S3I, S5I, and AP41I indicate immunity genes for the
associated S-type pyocin gene (A) and S1/I, S3/I, AP41/I, and S5/I indicate that
the associated immunity gene is present with the pyocin killing gene (B).
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Spatial variability in pyocin genotypes
To further understand whether the pyocin genotypes of our organisms
differed across spatial scale, we compared the total number of pyocin genes or a
subset of this, the killing genes, across the nine houses and two drain types. We
found that isolates from different houses varied with respect to the number of
immunity genes, but not in regard to the number of killing genes or total number
of pyocin genes. We found isolates from houses G, A, and H to encode the
highest number of total pyocin genes with averages of 3.5 genes per isolate.
These houses are followed by isolates from house F (3 genes per isolate), house
E (2.5 genes per isolate), houses C and D (2 genes per isolate), and house B
with an average of 1 pyocin gene per isolate. Additionally, we found that all
isolates within the same drain have identical pyocin genotypes for all the houses.
Furthermore, in four homes (B, C, D, and F), all isolates in both bathroom and
kitchen sink drains carry identical pyocin genotypes. However, isolates collected
from houses A, G, and H display differences in pyocin genotype across drains. A
general mixed linear model using “house” as a variable showed no significant
differences among all houses with respect to total pyocin gene content (p=0.076).
Isolates from houses G, A, H were found to carry the highest number of
pyocin killing genes with a mean of 3, 2,5, and 2.5 killing genes per isolate,
respectively, while houses C-F were found to carry an average of 2 killing genes
per isolate (Fig. 10B). House B was found to carry the lowest number of pyocin
killing genes per isolate with an average of 1 killing gene per isolate. Similar to
the total number of pyocin genes, “house” was not significant with respect to the
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number of killing genes (Fig. 10B, p=0.48)
Isolates from houses B, C, and D were not found to carry any known
immunity genes, while isolates from house A, F, and H were found to encode the
highest number of pyocin immunity genes with a mean number of 1 gene per
isolate. In contrast, isolates from house E and G were found to carry an average
of 0.5 immunity genes per isolate (Fig. 10C). Unlike the total number of pyocin
genes or just the killing genes, houses were significantly different in the number
of pyocin immunity genes (Fig. 10C, p=0.0018).
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Figure 10. Mean number of total pyocin genes (A), killing genes (B), and
immunity genes (C) per isolate across the eight homes in this study. Mean
number of genes are estimated marginal means with 95% confidence intervals.
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Bathroom isolates encode more genes than kitchen isolates
In previous studies, bathroom and kitchen sink drains were found to differ
in the likelihood that each of these drain types were to yield P. aeruginosa [74].
Furthermore, in our previous study [17], we found slight differences in pyocin
inhibition and susceptibility profiles between isolates collected from different drain
types. We therefore hypothesized that isolates collected from different drain
types would differ from one another in their pyocin gene content. We found that
isolates collected from bathroom sink drains encode significantly more pyocin
immunity genes and total number of pyocin genes compared to those collected
from kitchen sink drains (p=0.0093 and p=0.02, respectively) (Fig. 11A and C).
Isolates from bathroom sink drains also carry more genes for pyocin killing genes
than those from kitchen sink drains (Fig. 11B), but these differences are not
significant (p=0.181). Isolates from bathroom sink drains encode an average of
roughly 2.5 killing genes, 0.6 immunity genes, and 3.2 total pyocin genes per
isolate. Isolates from kitchen sink drains carry an average of 1.9 killing genes,
0.19 immunity genes, and roughly 2.1 total pyocin genes per isolate. These
results suggest that both drain type and house of origin appear to contribute to
pyocin genotype selection. Next, we sought to determine if the presence of
genes or combination of genes correlates with these isolates ability to kill other P.
aeruginosa isolates.
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Figure 11. Mean number of total pyocin genes (A), killing genes (B), and
immunity genes per isolate across bathroom and kitchen sink drains. Mean
number of genes are estimated marginal means with 95% confidence intervals.
*0.01 < p < 0.05; **0.001 < p < 0.01.

Relationship between pyocin genotype and the ability to kill other P.
aeruginosa isolates
We have previously reported on the interaction between these P.
aeruginosa isolates and their ability to kill other isolates in our collection [17]. To
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assess whether one type of pyocin is more potent than others, we calculated the
likelihood of inhibition for strains containing S-, R-, and F-type pyocins. As
shown in Figure 12B, strains bearing genes encoding R-type pyocins are more
likely to inhibit other strains. However, this experiment may be biased as strains
often bear two or more pyocin genes. Because of this, all individual pyocin
genotypes were then compared. To eliminate the role of immunity proteins in this
analysis, all interactions in which indicator isolates carried genes encoding
immunity proteins were excluded. Overall, pyocin killing gene combination
significantly affected the outcome of inhibitory interactions (p<0.001). We found
that isolates carrying only an R-type pyocin exhibited the highest predicted
probability of inhibition with a probability of 0.65 (Fig. 13). This was followed by
the genotypes S1-R, S3-R-F, and S2-R-F with predicted probabilities of 0.59,
0.53, and 0.47, respectively. Pyocin killing gene genotypes with the lowest
predicted probabilities of inhibition were S1-S5-R-F, S1-AP41-R, and S2-F
(predicted probabilities of 0.4, 0.4, and 0.18, respectively).
Finally, the roles of immunity proteins in P. aeruginosa interactions were
examined. We assessed whether the presence of an S-immunity gene in a strain
protected that isolate from inhibition by a producer carrying an S1 or S2 killing
gene. The predicted probability of inhibition was significantly higher for isolates
that were not found to carry the S1/S2 immunity gene when compared to those
isolates that did carry the immunity gene (Fig. 14, p=0.035).
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Figure 14. Predicted probability of inhibition when an immunity gene is present
or absent in the indicator isolate. Predicted probabilities are estimated marginal
means with 95% confidence intervals. *0.01 < p < 0.05.
Discussion
Pyocin genotype diversity in environmental isolates
We found that all 46 isolates in our collection encode genes for at least
one type of pyocin. These results are consistent with the findings of other
studies, particularly those of Olubukola et al. [135], who similarly found that all 24
of the CF isolates in their collection encoded genes for least one type of pyocin,
signifying the extremely high abundance of these narrow-spectrum antibiotics in
clinical isolates of P. aeruginosa. However, the prevalence of particular pyocin
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types in our study varies slightly from previous findings. Similar to our results,
Snopkova et al. [141] found some of the most commonly encoded pyocin genes
to be that of R and S2, which were present in their strains at 67% and 67.4%,
respectively, and were present in our strains at 63% and 43.5%. We found that
all of our isolates carried genes for at least one talocin, while 81.4% carried
genes for at least one S-type pyocin. Snopkova et al. [141] found S-type pyocins
in a greater abundance at 93%, and talocins were found at a lower abundance of
80%.
Similarly, Ghoul et al. [88] found S-type pyocins present at a rate of 98%
and Bakaal et al. [50] found these soluble pyocins present at a rate of 95%. Bara
et al. [55] observed that over 50% of the isolates in their study lacked genes for
S-type pyocins. The pyocin genotypes observed in our isolate collection vary
from those of other studies as we appeared to have far less unique pyocins in
comparison to that of Bara & Remold [55], who found the isolates in their study to
encode 41 unique pyocin gene combinations across the 116 isolates used in
their study, and Snopkova et al. [141], who observed 53 unique pyocin
genotypes in the 135 isolates used in their study. We found only seven unique
genotypes in the 46 isolates examined in our study.
The observation that our isolate collection differs from other studies in the
prevalence of particular pyocin genes and overall diversity in pyocin genotype
could exist because the origins of our strain collection are different from those of
other studies. Studies done by Snopkova et al. [141], Ghoul et al. [88], and
Bakaal et al. [50] involved the use of clinical strains derived from catheter
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infections, lung infections in individuals with CF, or non-CF isolates derived from
other human infections such as those in burns. The study done by Bara et al.
[55], which included environmental and CF-associated isolates, determined that
environmental isolates differed from those derived from individuals with CF in
terms of both pyocin phenotype and genotype. As such, it is possible that the
pyocin gene content differences between our study and others of could be the
result of differences in the environment of isolation. Another potential source of
variation could be in sampling bias. Our collection has isolates from nine houses.
If more houses had been sampled, it is possible that more genotypes would have
been detected.
Environmental and clinical isolates may differ in pyocin gene content due
to the potential role that pyocins play in mediating the outcome of competitive
interactions during initial infection. If the presumption that initially infecting strains
are environmental in nature is correct, the strains that are most likely to
outcompete and remain in the host environment may be able to do so due to a
competitive advantage provided by an abundance and diversity of pyocin genes.
Alternatively, isolates carrying fewer pyocin genes may have a competitive
advantage as they do not incur the cost of carrying and producing these
antimicrobials. It could also be that pyocin genes are pleiotropically linked to
other virulence factors that are important for initial colonization and persistence in
the host environment. Snopkova et al. [141] found a number of strong positive
and negative co-associations between pyocin genes and virulence genes,
suggesting a relationship between pyocin gene content and the ability to cause
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infection. For example, they found the presence of pyocin AP41 to have a strong
positive association with overall antibiotic resistance; however, other studies
have shown that the presence of the R/F pyocin gene cluster may increase
susceptibility to fluoroquinolones due to induction of the lytic system [142]. If
certain pyocin genes and virulence factors are pleiotropically linked, it could be
that certain pyocin genes are passively selected for or against along with genes
that play an important role in initial host colonization or persistence in the host
environment. More work is needed in examining the functional role that pyocin
production may play when isolates are initially colonizing the host environment
and if these genes continue to play an important role in allowing an isolate to
persist in the host environment or if these genes may only be passively selected
for during host colonization and subsequent adaptation.
Lastly, we found very distinct patterns in the S-type pyocin gene pairs in
our isolates as pyocins S1, S3, S5, and AP41 are always encoded in isolates
along with their cognate immunity protein. However, in our isolate collection,
pyocin S2 is never accompanied by an immunity protein. The presence of socalled “orphan” pyocin genes has been commonly identified across studies and
encompasses both orphan immunity genes in which an immunity gene is found
without its cognate killing gene and orphan killing genes in which killing genes
are present without an immunity gene [55, 88] . Our findings of only orphan killing
genes in pyocin S2 is difficult to interpret, as these immunity genes are presumed
to protect a producing cell so that a producer can be immune to its own pyocin
killing protein. There could be novel genes encoding immunity to the S2 pyocin
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that have yet to be discovered. Towards this, in our inhibition assays, we never
observed self-on-self inhibition, meaning that no isolate was able to inhibit itself
via pyocin production, which suggests that resistance to pyocins may be more
complex than previously thought and mediated not only through the presence of
immunity proteins, but potentially also through other mechanisms, perhaps
related to cell surface receptors or secondary immunity genes. More work is
needed to elucidate the mechanisms underlying the ability of the pyocin killing
gene to exist singly without an immunity gene, perhaps due to alternative
mechanisms of immunity.

Spatial isolation contributes to patterns of pyocin gene content
We examined differences in pyocin genotypes from isolates collected from
different homes and found that the genomes of these isolates were most likely to
differ in the number of pyocin immunity genes. The diversity in the number of
pyocin-encoding genes among isolates collected from different houses as well as
the limited diversity within drains and, to an extent, within homes is reasonable
based on our phenotypic observations of these isolates in laboratory inhibition
assays. We found a significant effect of house of the outcome of inhibitory
interactions as well as differences in both inhibition and susceptibility profile
among isolates from different houses [17]. Additionally, we found that isolates
from different houses were most likely to inhibit one another, followed by isolates
from different drains in the same house, and isolates from the same drain never
inhibited one another. Taken together, these pyocin phenotypic and genotypic
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observations confirm our conclusions from our previous study that historical
processes such as dispersal limitations across houses and, in some cases,
across drains within houses, contribute to the phenotypic patterns of pyocin
diversity observed in our strain collection [17]. However, without more information
on each of the houses in the sampling studying, we cannot rule out the potential
for contemporary abiotic or biotic conditions to play a role in contributing to
pyocin genotype or phenotype of the isolates in our study. Conditions such as
inputs into the drains, amount of water flow, cleaning habits, and characteristics
of the inhabitants of a home are contemporary processes that could impact the
drain populations of P. aeruginosa. More information on the environment of
isolation is needed to distinguish between the relative importance of historical
processes and current conditions in shaping patterns of pyocin diversity.

Current environmental conditions contribute to pyocin gene content
We examined pyocin gene content from isolates collected from different
drain types (bathroom and kitchen sink drains) and found that isolates derived
from bathroom sink drains encoded significantly more pyocin killing and immunity
genes when compared to those collected from kitchen sink drains. These results
are interesting because, in our previous study, we observed that bathroom sink
drain isolates were significantly less likely to inhibit kitchen sink drain isolates
[17]. However, based on our findings in this study and others [55], the total
number of pyocin genes does not appear to accurately predict the outcome of
pyocin-mediated interactions in laboratory settings. We propose that this is due
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to the extreme complexity of pyocin genetics as it involves not only killing and
immunity genes, but also an intricate regulatory system as well as receptor
variability that most certainly could account for a particular isolates likelihood of
being killing by a particular pyocin [80]. Furthermore, it could be that the number
of pyocin genes is not an important predictor in the outcome of inhibition, and
instead, the particular killing genes an isolate is carrying may indicate whether or
not it is more likely to inhibit when compared to other isolates.
Additionally, these findings indicate that, even across homes, isolates
collected from different sink drain types differ with respect to their pyocin
genotype. These findings suggest that there are factors, either abiotic or biotic,
contributing to differences in pyocin gene content in isolates collected from
different sink drains. Analyses of bacterial community composition in bathroom
and kitchen sink drains in our group have indicated that sink drain types differ
from one another and kitchen sink drains appear to have overall higher bacterial
diversity when compared to bathroom sink drains (A.A.M, unpublished data). It is
possible that the biological differences in drain types could account for the
differences observed in pyocin genotypes. If P. aeruginosa isolates face more
diverse competitors within the kitchen sink drain environment, producing a higher
number of pyocin genes may not provide a competitive benefit due to the costly
nature of carrying and releasing these antimicrobials [80, 82]. Furthermore, as
bacteriocins are primarily thought to mediate intraspecific interactions, pyocin
production may not be beneficial if the bacterial community is highly diverse and
composed of members of distant taxa. There could also be differences in abiotic
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factors between drain types such as resource availability and frequency of use.
More work would be needed in characterizing specific abiotic and biotic
differences in drain types to elucidate the mechanisms driving differences in
pyocin gene content observed among isolates collected from bathroom and
kitchen sink drains.

Isolates carrying only R-type pyocins are most likely to inhibit
While several previous studies have focused on pyocin genotype diversity
and overall abundance of pyocin genes in P. aeruginosa populations, few studies
have investigated the extent to which different pyocin killing genes and
combinations of killing genes contribute to the outcome of inhibitory interactions.
We investigated the differences in the probability of inhibition for seven different
pyocin killing gene genotypes in interactions in which the indicator isolates carry
no immunity genes to S-type pyocins. We found producer isolates carrying genes
encoding for an R-type pyocin to have the highest probability of inhibition, while
isolates carrying genes for S2 and F-type pyocins to have the lowest likelihood of
inhibition in our study (Fig. 13).
Our finding that isolates carrying genes encoding for an R-type pyocin had
the highest predicted probability of inhibition are reasonable in the context of a
study done by Oluyombo et al. [135] in which R-type pyocins were found to play
a significant role in the outcome of inhibitory interactions among CF isolates of P.
aeruginosa; R-pyocin deletion mutants were observed to lose the capacity for
inhibition when compared to their R-pyocin carrying counterparts. These
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observations were consistent across both planktonic cultures and growth in a
biofilm. Furthermore, when an R-sensitive strain was grown in a biofilm and
treated with purified R-type pyocin, a significant decrease in the number of viable
cells was observed. Similar conclusions have been drawn in other studies in
which R-type pyocins appear to significantly contribute to inhibitory interactions in
clinical isolates of P. aeruginosa [50, 143]. This could be due to the relative high
potency of R-type pyocins when compared to other types of pyocins; it has been
shown that a single molecule of an R-pyocin can kill a sensitive cell whereas
100-200 F-pyocin molecules and as many as 300 S2 pyocin molecules are
needed to inhibit a competitor [114, 144, 145]. Furthermore, induction of R-type
pyocin genes can result in the production of 200 pyocin molecules per cell [146].
Interestingly, however, when an R-type pyocin is present with other killing
genes such as an S-type pyocin (S1, S5, AP41, S3) and an F-type pyocin, the
predicted probability of killing decreases. These findings are somewhat
counterintuitive as it might be logical that a higher number of pyocin killing genes
would provide a producer with the ability to inhibit a higher number of isolates.
One explanation of this observation could relate to differential gene expression of
pyocin killing genes. Numerous studies have confirmed that all pyocin killing and
immunity genes are regulated in the same RecA-mediated manner; however, it
has not yet been investigated if pyocin genes will be differentially expressed
when they are present in combination with one another compared to when they
are present singly in a producing cell. It is possible that we observed the highest
rate of inhibition in isolates that carry only an R-type pyocin gene because the
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presence of a single killing gene allows for more expression whereas, if multiple
killing genes are present, expression levels of each gene may be lower to allow
for concurrent expression.
Another explanation for differences observed between interactions in
which R is present alone and found with other pyocin killing genes could be
related to talocin subtypes as we did not sub-type the R or F pyocins in this study
and it is well-known that different talocin subtypes (R1-R5; F1-F3) differ in their
receptor specificity and, as a result, differ in their killing range. Furthermore, we
do not know the specific components of LPS, the receptor for R- and F-type
pyocins, for each of the isolates in this study. Consequently, the specifics of how
particular pairs of producer and indicator isolates interact with one another
regarding their talocins are unclear. We may lack sufficient information to
understand the entirety of our data.

Presence of an immunity gene provides protection
We found that, overall, isolates carrying an S1S2 immunity gene have a
significantly lower probability of being inhibited by isolates carrying S1 or S2
pyocin killing genes. These results are logical as they indicate that the presence
of a gene encoding for an S immunity protein protects an isolate that is the target
of the corresponding S killing protein. Despite this finding, however, there are two
interesting observations of note in these results. The first is that, although
isolates with an immunity gene are less likely to be inhibited, there is still a
probability of 0.15 that an isolate with a gene for an S1/S2 immunity protein will
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be inhibited by an isolate carrying a gene for an S1 or S2 killing protein. It is
possible that, in these cases, perhaps the S1/S2 immunity was not expressed or
was not expressed at levels sufficient enough to provide protection for the
indicator.
It should be noted that, in our inhibition assay, pyocin expression was
induced using a DNA damaging agent, mitomycin C, only in producer isolates, so
it is possible that the indicator isolate was not expressing the immunity gene or is
only expressing it at low levels that are not sufficient to evade inhibition by the
producer. Studies have shown that S6 pyocin immunity genes have higher levels
of basal expression than the S6 killing protein [89]; however, it is unclear if this
phenomenon is also observed in other S-type pyocin genes such as the S1/S2
immunity gene. Alternatively, isolates carrying a gene encoding for the S1/S2
immunity protein may still be susceptible to inhibition by the producer isolate if
the killing results from mechanisms other than S2 pyocin production. While our
inhibition assay method allowed us to rule out contact-dependent inhibition (CDI),
we could not rule out inhibition through other mechanisms such as
bacteriophage, other secreted antimicrobials, or even other pyocin types that
were not characterized in this study. The second result of note is that not all
isolates lacking an immunity gene are susceptible to a producer carrying a gene
for the S2 killing protein. These isolates may not be susceptible due to other
immunity mechanisms such as receptor incompatibility. More research is
warranted to investigate basal level expression of pyocin killing and immunity
genes as well as alternative mechanisms of pyocin resistance. Furthermore, it
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should be noted that isolates carrying S1 or S2 pyocin genes also carried genes
for R- and/or F-type pyocins, which could impact the trends observed in our
study, as an R- or F-type pyocin could be responsible for killing activity in
addition to an S-type pyocin in these interactions. None of the isolates in our
study were found to carry only one S-type killing gene. Given this limitation, we
were unable to distinguish between inhibition due to talocins or S-type pyocins in
our inhibition assays. Therefore, we are cautious with the conclusions in this
portion of our study and more investigation is needed into the potential protection
that an immunity protein may provide from an S-type pyocin.

Conclusion
This study aimed to characterize patterns of diversity in pyocin gene
content among household isolates and investigate potential ecological,
evolutionary, and genetic drivers of these patterns. We found that isolates from
different houses differ primarily with respect to the total number of immunity
genes found in each isolate, but do not significantly differ in the total number of
all pyocin genes, suggesting a weak relationship between historical events such
as dispersal limitations and pyocin gene content. Isolates collected from
bathroom sink drains encoded significantly more killing and immunity genes,
indicating that the current conditions, either abiotic or biotic, may play an
important role in shaping patterns of diversity in pyocin genetics. Finally, isolates
with S-type immunity genes have a significantly lower probability of being
inhibited by S-type killing proteins, and isolates producing only R-type pyocins
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exhibit the highest likelihood of inhibition than all other killing gene combinations.
Overall, it appears that both dispersal limitations and local adaptation to current
environmental conditions contribute in some capacity to pyocin genotype.
Additionally, particular pyocin genotypes are more adept at killing than others,
and S-type immunity genes protect isolates from being killing; however, it is likely
that alternative mechanisms of resistance also play a role in the outcomes of
inhibition. Furthermore, the massive complexity of the pyocin genetic system
does not allow us to completely understand the genetic and mechanistic
processes that are responsible for the outcomes of inhibitory interactions.
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APPENDIX
Table 4. S-type pyocin genes screened in all genomes and reference genomes
used to retrieve gene sequences.
pyocin

gene function

gene name/locus
tag

S2

killing protein

pys2 (PA1150)

S1 and
S2

immunity
protein

imm2 (PA1151)

S1

killing protein

A4W92_RS05830

S3

killing protein

pyoS3A
(PA14_49520)

Pseudomonas aeruginosa PAO1
(Reference)*
Pseudomonas aeruginosa PAO1
(Reference)
Pseudomonas aeruginosa ATCC
278534†
Pseudomonas aeruginosa UCBPPPA14‡

S3

immunity
protein

pyoS3I (PA14_49510)

Pseudomonas aeruginosa UCBPP-PA14

S5

killing protein

pyoS5 (PA0985)

S5

immunity
protein

PA0984

AP41

killing protein

PADK1_RS07240

immunity
PADK1_RS07235
protein
*RefSeq Assembly Accesstion GCF_000006765.1
†RefSeq Assembly Accession GCF_001618925.1
‡RefSeq Assembly Accession GCF_000014625.1
§RefSeq Assembly Accession GCF_900069025.1
AP41
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genome

Pseudomonas aeruginosa
PAO1 (Reference)
Pseudomonas aeruginosa PAO1
(Reference)
Pseudomonas aeruginosa
DK1 substr. NH57388A§
Pseudomonas aeruginosa
DK1 substr. NH57388A

Table 5. R- and F-type pyocin genes screened in all isolate genomes.
pyocin

gene function

gene name/locus
tag

R and
F
R and
F

anthranilate
synthetase I
Transcriptional
repressor
Transcriptional
activator

-

Repressor

ptrB (PA0612)

-

Hypothetical protein

PA0613

R and
F

Holin

PA0614

-

Hypothetical protein

PA0615

R

Tail spike

PA0616

R

Tail baseplate

PA0617

R

Tail baseplate

PA0618

R

Tail formation

PA0619

R

Tail fiber

PA0620

R

Tail fiber

PA0621

R

Tail sheath

PA0622

R

Tail tube

PA0623

R

Hypothetical protein

PA0624

R

Tail formation

PA0625

R

Tail formation

PA0626

R

Tail formation

PA0627

R

Tail formation

PA0628

R and
F

Lytic enzyme

PA0629

F

Tail protein

PA0630

F

Tail formation

PA0631

F

Tail formation

PA0632

F

Tail protein

PA0633

-

trpE (PA0609)
prtR (PA0610)
prtN (PA0610)
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genome
Pseudomonas aeruginosa PAO1
(Reference)
Pseudomonas aeruginosa PAO1
(Reference)
Pseudomonas aeruginosa PAO1
(Reference)
Pseudomonas aeruginosa PAO1
(Reference)
Pseudomonas aeruginosa PAO1
(Reference)
Pseudomonas aeruginosa PAO1
(Reference)
Pseudomonas aeruginosa PAO1
(Reference)
Pseudomonas aeruginosa PAO1
(Reference)
Pseudomonas aeruginosa PAO1
(Reference)
Pseudomonas aeruginosa PAO1
(Reference)
Pseudomonas aeruginosa PAO1
(Reference)
Pseudomonas aeruginosa PAO1
(Reference)
Pseudomonas aeruginosa PAO1
(Reference)
Pseudomonas aeruginosa PAO1
(Reference)
Pseudomonas aeruginosa PAO1
(Reference)
Pseudomonas aeruginosa PAO1
(Reference)
Pseudomonas aeruginosa PAO1
(Reference)
Pseudomonas aeruginosa PAO1
(Reference)
Pseudomonas aeruginosa PAO1
(Reference)
Pseudomonas aeruginosa PAO1
(Reference)
Pseudomonas aeruginosa PAO1
(Reference)
Pseudomonas aeruginosa PAO1
(Reference)
Pseudomonas aeruginosa PAO1
(Reference)
Pseudomonas aeruginosa PAO1
(Reference)
Pseudomonas aeruginosa PAO1
(Reference)

F

Tail protein

PA0636

F

Hypothetical protein

PA0637

F

Tail protein

PA0638

F

Tail protein

PA0639

F

Hypothetical protein

PA0640

F

Hypothetical protein

PA0641

F

Hypothetical protein

PA0642

F

Hypothetical protein

PA0643

F

Hypothetical protein

PA0644

F

Hypothetical protein

PA0645

F

Hypothetical protein

PA0646

F

Hypothetical protein

PA0647

F

Hypothetical protein

PA0648

-

anthranilate
synthetase II

trpG (PA0649)

116

Pseudomonas aeruginosa PAO1
(Reference)
Pseudomonas aeruginosa PAO1
(Reference)
Pseudomonas aeruginosa PAO1
(Reference)
Pseudomonas aeruginosa PAO1
(Reference)
Pseudomonas aeruginosa PAO1
(Reference)
Pseudomonas aeruginosa PAO1
(Reference)
Pseudomonas aeruginosa PAO1
(Reference)
Pseudomonas aeruginosa PAO1
(Reference)
Pseudomonas aeruginosa PAO1
(Reference)
Pseudomonas aeruginosa PAO1
(Reference)
Pseudomonas aeruginosa PAO1
(Reference)
Pseudomonas aeruginosa PAO1
(Reference)
Pseudomonas aeruginosa PAO1
(Reference)
Pseudomonas aeruginosa PAO1
(Reference)

16−011
16−013
16−015
16−017
16−020
16−022
16−032
16−034
16−042
16−043
16−051
16−052
16−056
16−057
16−059
16−074
17−042
17−045
17−046
17−047
17−048
17−052
17−054
17−055
17−056
17−057
17−058
17−059
18−001
18−002
18−004
18−008
18−010
18−011
18−013
18−017
18−019
18−021
18−022
18−024
18−027
18−029
18−031
18−036
18−038
18−056
PAO1
trpE
prtR
prtN
ptrB
PA0613
PA0614
PA0615
PA0616
PA0617
PA0618
PA0619
PA0620
PA0621
PA0622
PA0623
PA0624
PA0625
PA0626
PA0627
PA0628
PA0629
PA0630
PA0631
PA0632
PA0633
PA0634
PA0635
PA0636
PA0637
PA0638
PA0639
PA0640
PA0641
PA0642
PA0643
PA0644
PA0645
PA0646
PA0647
PA0648
trpG

Figure 8. Presence/absence of all genes in the R/F pyocin gene cluster for each
isolate. Grey squares indicate that the gene is present in that particular isolate,
and white squares indicate that the gene is absent in that particular isolate.
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